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Methanococcus jannaschii is a thermophilic methane producing archaebacterium.  In this
organism genes encoding the aspartate transcarbamoylase (ATCase) catalytic (PyrB) and
regulatory (PyrI) polypeptides were found.  Unlike Escherichia coli where the above
genes are expressed from a biscistronic operon the two genes in M. jannaschii are
separated by 200-kb stretch of genome.  Previous researchers have not been able to show
regulation of the M. jannaschii enzyme by the nucleotide effectors ATP, CTP and UTP.
In this research project we have genetically manipulated the M. jannaschii pyrI gene and
have been able to assemble a 310 kDa E. coli like enzyme.  By using the second
methionine in the sequence we have shown that the enzyme from this organism can
assemble into a 310 kDa enzyme and that this enzyme is activated by ATP, CTP and
inhibited by UTP.  Thus strongly suggesting that the second methionine is the real start of
the gene.
The regulation of the biosynthetic pathway in Pseudomoans aeruginosa has previously
been impossible to study due to the lack of CTP synthase (pyrG) mutants.  By
incorporating a functional uridine (cytidine) kinase gene from E. coli it has been possible
to isolate a pyrG mutant.  In this novel mutant we have been able to independently
manipulate the nucleotide pools and study its effects on the enzymes in the biosynthetic
pathway.   The enzyme asapartate transcarbamoylase was repressed 5-fold when
exogenous uridine was high and cytidine was low.  The enzyme dihydroorotate was
repressed 9-fold when uridine was high.  These results suggest that a uridine compound
may be the primary repressing metabolite for the enzymes encoded by pyrB and pyrC.
This is the first study to be done with the proper necessary mutants in the biosynthetic
pathway of P aeruginosa.  In the past it has been impossible to vary the internal UTP and
CTP pools in this organism.
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In 1996 Bult et al. reported the complete genome sequence of Methanococcus
jannaschii. The size of the entire genome was reported to be 1.66 mega-bases, which
included two plasmids of 58 kb and 16 kb respectively.  A total of 1738 protein
coding genes were identified, though only 38% of them were assigned putative
cellular roles.  The complete genome sequence of this thermophilic autotrophic
archaeon allowed for the first time the ability to compare genetic components and
biochemical pathways among the three domains of life.
In 1977 Fox and Woese proposed the placement of Archaebacterium into a
distinct kingdom of its own.  Although Archaea are cytoplasmically prokaryotic in
nature, they are related at the molecular level more specifically to Eukaryota.  Many
of the genes related to transcription, translation, and replication are more similar to
those found in Eukaryota, although one does find genes that are required for cell
division and central metabolism to bear resemblance to Prokaryota genes.
There are three orders that comprise the methanogens, the
Methanobacteriales, the Methanococcales and the Methanomicrobiales.  The
Methanococcales have one family Methanococcaceae, and one genus
Methanococcus, which is composed of six species of themophilic and mesophilic
organisms.  Members of this genus are Gram-negative or Gram-positive irregular
cocci, 1-2 μm in diameter.  M. jannaschii is the most extensively studied of the six
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species in the genus Methanococcus (Fig 1).  Leigh (1983) first isolated M. jannaschii
from a sediment sample collected from the sea floor surface at the base of a 2600 m
deep hydrothermal vent in the East Pacific Rise and the Guaymus Basin (Jones et al,
1983). M. jannaschii can grow at pressures of up to 200 atm and has an optimal
temperature for growth of 85◦C, a pH growth optimum of 6.0  7.0 and grows
optimally at a salinity of 0.4  0.7 M NaCl.  M. jannaschii utilizes hydrogen (H2) and
carbon dioxide (CO2) as substrates for methanogenesis.  When growing on H2 and
CO2, the methanogens are autotrophic with CO2 serving as both a carbon source and
as the electron acceptor.  Formate can act as an electron acceptor to be reduced to
methane (CH4) for one of the three strains of M. jannaschii.
3
Fig 1.  Photomicrograph of M. jannaschii seen as irregular cocci.  Adapted from The
Methanococcus jannaschii functions database.
Web address http://geta.life.uiuc.edu/~nikos/Methanococcus_jannaschii.html
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Synthesis of pyrimidine nucleotides de novo
The pyrimidine biosynthetic pathway has been studied in detail in bacteria
(Yates & Pardee, 1956a, 1956b, 1957; Beckwith et al., 1962; Hayward & Belser,
1965; Yan & Demerec, 1965; Hutson & Downing, 1968; Isaac & Holloway, 1968;
Condon et al., 1976, Foltermann et al., 1981; Grogan & Gunsalus, 1993), fungi
(Lacroute, 1968; Caroline, 1969), plants (Kafer & Thornburg, 1999) and mammals
(Hager & Jones, 1967; Nakinishi et al., 1968; Jones, 1980).
There are nine enzymatic steps, which ultimately result in the formation of the
pyrimidine ribonucleotides UTP and CTP (Fig 2).  The pyrimidine ring is assembled
first and then linked to ribose phosphate to form the initial pyrimidine nucleotide
OMP.  The precursors of the pyrimidine ring are carbamoylphosphate and aspartate.
The initial step in the pathway is the formation of carbamoylphosphate, which is
produced in the reaction catalyzed by carbamoylphosphate synthetase (CPSase;
carbamoylphosphate: L-aspartate carbamoyltransferase, EC 6.3.55).
Carbamoylphosphate plays a dual role, being required not only for pyrimidine but
also for arginine biosynthesis.   The carAB genes encode CPSase in Escherichia coli.
Figure 6 shows the fate of carbamoylphosphate in overall microbial metabolism.
The next step in the pathway involves the carbamoylation of aspartate by
aspartate transcarbamoylase (ATCase; EC 2.1.3.2) to form N-carbamoylaspartate and
inorganic phosphate.  This reaction is the first committed step in the synthesis of
pyrimidine nucleotides de novo.  The genes encoding ATCase in E. coli are pyrBI and
in Pseudomonas are pyrBC' .
Carbamoylaspartate cyclizes with the loss of water to yield dihydroorotate.  At
this stage the pyrimidine ring has formed.  The reaction is catalyzed by
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dihydroorotase (DHOase; EC 3.5.2.3) encoded by the pyrC gene.  The dihydroorotate
so formed is then oxidized to orotate by dihydrooorotate dehydrogenase (DHOdehase;
EC 1.3.3.1) encoded by pyrD.  DHOdehase is a flavoprotein which is membrane
associated.
The next step in the pathway involves the acquisition of a ribose phosphate
group.  Orotate phosphoribosyltransferase (OPRTase; EC 2.4.2.10) catalyzes the
reaction where orotate a free pyrimidine, reacts with PRPP to yield orotidine-5-
monophosphate (OMP) and pyrophosphate.  This reaction is driven forward by the
hydrolysis of pyrophosphate.  The pyrE gene encodes the enzyme is responsible for
this conversion.
Decarboxylation of OMP is carried out by OMP decarboxylase (OMPdecase;
EC 4.1.1.23), which yields uridine-5- monophosphate (UMP).  The pyrF gene
encodes OMP decarboxylase. UMP is then phosphorylated by a specific UMP kinase
to form uridine-5-diphosphate (UDP).  UMP kinase (UMPK; EC 2.7.4.4) utilizing
the gamma phosphate of ATP.  UTP is produced by the phosphorylation of UDP by
nucleoside diphosphokinase.  (NDK; EC 2.7.4.6)
The final step in the pyrimidine pathway is the amination of UTP to cytidine-
5-triphosphate (CTP) by the enzyme CTP synthetase.  (CTPsase; EC 6.3.42).  For
this enzyme, encoded by pyrG, glutamine serves as the amino donor for the
amination.
ATCase is an especially interesting regulatory enzyme.  ATCase from E. coli
is one of the most highly characterized enzymes. The nature of this enzyme in M.
jannaschii, E. coli and in Pseudomonas species will be discussed later.
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Recycling of pyrimidine and purine nucleotides
Pyrimidine nucleotide biosynthesis can be divided into three phases
(ODonovan et al, 1989).  Phase 1 involves the production of the pyrimidine
ribonucleotides UTP and CTP.  Phase 2 yields the deoxyribonucleotides dCTP and
the ultimate pyrimidine nucleotide dTTP.  The final phase, phase 3 involves the
salvage pathways.  The salvage phase can be divided into two parts, the
ribonucleotide salvage pathway and the second one being the deoxyribonucleotide
salvage pathway (Fig 3).  The nucleotide salvage pathway functions to supply the
pentose portions of nucleotides and nucleosides as carbon and energy source and the
amino group of cytosine compounds as nitrogen source.  Pyrimidine bases and
nucleosides are returned to the pool as triphosphates and thus are recycled and not
excreted into the medium.
The salvage pathway in prototrophs provides a balance between RNA
synthesis and the biosynthetic pathway, while it supplies all the necessary
requirements for pyrimidines in auxotrophs (ODonovan & Shanley, 1995).  Figure 3
shows the salvage enzyme pathway in the archetype organism E. coli.  The latter half
of this dissertation deals specifically with the salvage pathway, which is discussed in
greater detail in Chapter II.
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       RNA                                                                       RNA
CTP UTP
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     C U
Fig 3.  Pyrimidine salvage pathway in Escherichia coli.  Enzymes are 1. uracil
phosphoribosyltransferase (Upp), 2. uridine phosphorylase (Udp), 3. ribonucleoside
hydrolase A & B (Rih), 4. cytosine deaminase (Cod), 5. cytidine deaminase (Cdd), 6.
uridine kinase (Udk), 7. 5-nucleotidase, 8. CMP glycosylase, 9. CMP kinase (Cmk)
de novo
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Classification of  bacterial aspartate transcarbamoylase
Bacterial ATCases are divided into three classes.  Bethell & Jones (1969) first
proposed these classes, namely Class A, Class B and Class C.  The classification is
based on the molecular weight of the ATCases and their response to the nucleotide
effectors (ATP, CTP and UTP).
Class B ATCase, in which the enzymes of E. coli and other
Enterobacteriaceae have been placed has a molecular mass of approximately 300 kDa
and shows sigmoid saturation curves with both substrates, aspartate and
carbamoylphosphate.  The subunit structure of Class B ATCase is 2(c3): 3(r2).
Class C ATCases are the smallest in size and have a molecular mass of 100-
140 kDa.  Class C enzymes are not regulated and are simple catalytic trimers (c3).  A
representative within this class of ATCases is the Bacillus subtilis enzyme, which has
a structural organization of (c3).
The largest ATCases are those that belong to Class A and have been studied in
the genus Pseudomonas.  The ATCase of P. fluorescens (Neumann & Jones 1964;
Adair & Jones 1972), P. putida (Condon, et al., 1976; Shurr et al., 1995), P.
aeruginosa (Isaac & Holloway, 1968) and Burkholderia cepacia (Linscott, Ph.D.
dissertation, 1996) have all been extensively studied.  Purified ATCase from P.
fluorescens was thought to be a dimer (Neumann & Jones, 1964; Adair & Jones,
1972) until it was shown to consist of a 1:1 ratio of 34-kDa and 45-kDa polypeptides,
which are arranged in a dodecamer (Bergh & Evans 1993).  The KM for aspartate in
this study was reported to be 2.75 mM and that for carbamoylphosphate to be 14 µm.
ATCase of P. aeruginosa (Isaac & Holloway 1968, Schurr et al., 1995) was reported
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to have a molecular mass of 480 kDa, whilst the KM of aspartate in this species was
1.3 mM.  ATP and UTP inhibited the enzyme.  CTP was also an inhibitor but not to
the same extent as ATP and UTP.  The ATCase of P. putida (Condon et al., 1976)
was reported to be inhibited by pyrophosphate, ATP, UTP and CTP.  When
carbamoylphosphate was limiting, CTP was the most influential inhibitor of the
enzyme.  The structural organization of the Class A ATCase encoded by pyrBC in
Pseudomonas species is dodecameric and may be represented as follows 2B3: 3C2.
Schurr et al, (1995) showed that the ATCase of P. putida required an inactive
DHOase to be functional.
Hughes et al, (1999) conducted an extensive study of  the ATCase of
Streptomyces griseus.  In this organism, hyperbolic curves were obtained for ATCase
activity when velocity-substrate plots for aspartate and carbamoylphosphate were
made.  The ATCase enzyme was inhibited by ATP, CTP, UTP and GTP.  This is
typical of Class A ATCase found in other organisms.  Purification studies of ATCase
and DHOase showed that the two activities were present as a single enzyme complex.
Two other organisms, namely Deinococcus radiophilus and Thermus aquaticus also
show this ATCase/DHOase activity in their holoenzyme structure.  Many more
organisms may also possess this unique complex.  This led Hughes et al, (1999) to
suggest a subtyping of the Class A ATCases. Class A1 ATCases would be those that
have both ATCase and DHOase activity and Class A2 would be those that have
degenerate DHOase subunits as one finds in Pseudomonas.  Figure 4 shows all the
classes of ATCases.
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Regulation by transcriptional attenuation of E. coli pyrBI operon
The pyr genes can be regulated by mechanisms of transcriptional and
translational attenuation.  In E. coli the catalytic and the regulatory polypeptides of
ATCase are expressed from adjacent genes, pyrB and pyrI respectively, which are
present in a bicistronic operon.  The pathway for pyrimidine biosynthesis is regulated
at the level of enzyme synthesis by attenuation (Roof et al., 1982; Turnbough et al.,
1983; Schachman, 1983) and enzyme activity is regulated by allosteric inhibition by
nucleotide effectors (Gerhart & Pardee, 1962, 1964).
The pyrBI genes encoding ATCase and the pyrE gene encoding OPRTase all
have upstream leader sequences that allow for attenuational control.
Turnbough et al, (1983) reported the presence of two promoter regions located at 
350 bp and 160 bp upstream of the translational start of the pyrB gene.  The
promoter region located at 160 bp was observed to be more active in vivo than the
region located at 350 bp (Navre & Schachman, 1983).  Transcripts initiated at both
promoters are terminated at a region of dyad symmetry, 40 bp from the start of the
pyrB gene.  The rho-independent terminator is high in GC residues, which allows for
the formation of a stem loop secondary structure.  The stem loop structure is followed
by a string of uridine residues, which typifies other attenuators found in some amino
acid biosynthetic operons.  A second stem loop formation can also be observed at 
100 bp upstream of the pyrB start (Fig 5a).
Based on the information a model has been proposed for the mechanism of
attenuational control of pyrimidine biosynthesis in E. coli.
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At high intracellular levels of UTP, RNA polymerase transcribes the message through
the region of dyad symmetry.  This allows for the formation of the stem loop
secondary structure corresponding to the termination loop and transcription is
terminated.  Therefore the structural genes are not transcribed (Fig 5b).
At low UTP concentrations, the RNA polymerase pauses at a site located 80
bp from the start of the pyrB gene.  This pausing allows the translating ribosome to
catch up, and this linking does not allow the formation of the stem loop structure.
The coupling of the ribosome and RNA polymerase allows for the transcription of the
pyrBI operon and the subsequent expression of ATCase (Fig 5c).
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Fig 5a Promoter-Regulatory Region
Fig 5b High UTP-No or Weak Transcriptional Pausing
 pyrBI promoter
Transcriptional



















Regulation of pyrimidine biosynthesis at the level of enzyme activity in E. coli and
Pseudomonas.
Enzyme activity is controlled at three steps in the de novo synthesis of
pyrimidines in E. coli.  CPSase, is inhibited by UMP and activated by ornithine and IMP.
ATCase the first committed step in the pathway is inhibited by CTP and UTP, and
activated by ATP (Gerhart & Pardee, 1962).  CTP synthetase encoded by my favorite
gene, pyrG, is inhibited by CTP and activated by UTP (Long and Pardee, 1967; Long and
Koshland, 1978).
In the genus Pseudomonas regulation at the level of enzyme activity is similar to
that found in E. coli.  CPSase activity is inhibited by UMP and activated by ornithine and
N-acetylornithine (Abdelal et al., 1983).  ATCase activity which is encoded by pyrBC is
inhibited by ATP, CTP and UTP (Issac and Holloway, 1968; Condon et al, 1976;
Vickrey, 1993;  Schurr et al, 1995).
Regulation by attenuation of the Bacillus subtilis pyrimidine biosynthetic (pyr) gene
cluster
In Bacillus subtilis the pyr map as a single gene cluster on the chromosome
(Lerner & Switzer, 1986).  All of the genes on the cluster are expressed as a single
polycistronic transcriptional message.  Transcription is controlled by the availability of
UTP.  Switzer et al (1999) have shown that it is controlled by an attenuation mechanism.
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Transcriptional attenuation is controlled at three sites within the 5 sequence of the
transcript.  The first gene in the cluster is a UMP- dependent RNA binding protein
encoded by pyrR.  When pyrimidine nucleotide levels are high (UTP) in the B. subtilis
cell, UMP binds to the PyrR protein.  This in turn binds to the pyr mRNA in a sequence
specific manner.  This binding promotes the formation of a rho-independent terminator,
which inhibits the expression of the downstream pyr genes (Lu et a.l, 1995; Lu and
Switzer, 1996; Turner et al., 1998; Switzer et al., 1999).
Regulation of pyrimidine biosynthesis in Pseudomonas.
Various researchers (Isaac & Holloway, 1968; Condon et al., 1976) have tried to
elucidate the regulation of pyrimidine biosynthesis in the pseudomonads.  Regulation of
pyrimidines in Pseudomonas has been elusive and researchers have yet to ascertain the
control of the pathway.  It has not been possible to study the mechanism of control at the
level of gene expression.  However research in our lab (Patel & Kumar, unpublished
data) have studied the presence of a regulatory protein, PyrR, in  P. aeruginosa upstream
of the pyrBC genes.  The pyrR gene product is thought to regulate the expression of the
later pyrimidine genes, pyrD, pyrE and pyrF by binding to a specific sequence.  PyrR is
also thought to autoregulate its own expression.
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Aspartate transcarbamoylase of thermophiles and hyperthermophiles
       Microorganisms have the ability to inhabit almost any enviroment.  The discovery
of life in extreme conditions opened up a whole new perspective on the fundamentals of
applied biology.  Extremophiles are organisms that can thrive in extreme conditions.
These include those organisms that can withstand very low temperatures (between 0◦C
and 10◦C) as in the case of the psychrophiles.  Thermophiles and hyperthermophiles are
organisms that can withstand very high temperatures (60◦C to 113◦C).  Organisms that
can survive at pressure (40 atm) are known as barotolerant organisms or barophiles.
Alkalophiles are those organisms that can survive at pH>10 and acidophiles are those
that can survive at pH 3.0 or lower.  All these organisms are prokaryotes belonging to
the eubacterial or archaea domains of life (Cunin, 1997).  The ATCases of many of these
organisms provide insights into the ancestral forms of the enzyme and therefore it is
important to study the enzymes in these extremophiles.  As in all bacteria,
carbamoylphosphate (CP) is required in the arginine and pyrimidine biosynthetic
pathways.  Fig. 6 shows the many pathways in which CP is involved.  CP is a highly
thermolabile metabolite and it may even be toxic at high temperatures by being converted
to cyanide.  Therefore, thermophilic bacteria must have evolved strategies to protect
against degradation of CP and its possible toxic effects.  Thus, it is important to study
these two intertwined pathways.  ATCase appears to be ubiquitous and therefore its study
in extremophilic archaea and eubacteria is useful when one considers it for comparative
phylogenetic studies.
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The genes for ATCase from all of the following bacteria have been studied.
Thermus aquaticus ZO5 (Van de Casteele et al., 1997), Thermus thermophilus,
Thermatoga maritima, Pyrococcus abyssi and Sulfolobus solfataricus ATCases have all
been cloned and subsequently characterized by complementing a pyrB  deficient E. coli
strain.  All of the ATCases from T. aquaticus, P. furiosus, P. abyssi, T. maritima and S.
solfataricus are regulated (Van de Casteele, 1994 and Purcarea et al., 1994).  All show
cooperativity for the use of aspartate in that velocity-substrate plots are sigmoidal for
both aspartate and carbamoylphosphate.
P. abyssi ATCase shows cooperativity for the use of aspartate and carbamoylphosphate.
(Van de Casteele, 1994 and Purcarea, 1995).  The ATCase of  T. maritima and P.
furiosus is inhibited by UTP and CTP, whilst the enzyme from T. aquaticus is inhibited
by UTP (Van de Casteele, 1994; Purcarea et al., 1994; Van de Casteele, 1997). Enzyme
assays conducted at 37◦C showed that the P. abyssi ATCase was inhibited by CTP, UTP
and activated by ATP.  When the same assay was performed at 90◦C it was observed that
the enzyme was inhibited by CTP only.  UTP, CTP and ATP activate the S. solfataricus
enzyme.
When the catalytic polypeptides of ATCase (pyrB) and the regulatory (pyrI)
polypeptides are aligned from the extremophiles and E. coli it can be seen that there are
strong similarities between them.  Fig. 7 shows the pyrB alignments from various
organisms and Fig. 8 shows the pyrI alignments from various organisms.  In S.
solfataricus the pyrBI genes are organized as part of a pyrB I- pyrE divergent operon.
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This type of arrangement for pyrimidine genes is novel when one compares it to other
closely related organisms.
As pointed out earlier the entire genome of M. jannaschii has been sequenced
(Bult et al., 1996) and it has been shown that two ORFs show similarity to the P. abyssi
and S. solfataricus pyrB and pyrI genes.  In E. coli, the two genes are present as part of a
pyrBI  bicistronic operon.  In M. jannaschii the two coding regions are separated by a 200
kb stretch of genome.  Genes that are unrelated to the metabolism of CP are present
within this 200 kb space.  When one aligns the pyrB gene product of E. coli and M.
jannaschii they exhibit 47% amino acid identity and 67% amino acid similarity (Fig 9)
are exhibited between them.  Amino acid comparison of the M. jannaschii PyrI protein
shows 35% identity and 52% similarity to the E. coli PyrI protein (Fig 10).  Residues
comprising the zinc binding site and nucleotide effector binding sites are all conserved in
the M. jannaschii PyrI.  M. jannaschii differs from other recently characterized ATCases
from other archaeabacteria (P. abyssi and S. acidocaldarius), which contain an
enterobacteria-like pyrBI operon (Purcarea et al., 1997 and Durbecq et al., 1999).
It seemed important to ascertain if the M. jannaschii PyrB and the PyrI
polypeptides were capable of assembly into an active 310 kDa E. coli like ATCase and if
the putative complex could be regulated.
22
In this chapter we present data to show that the M. jannaschii ATCase has the capacity to
assemble into an E. coli like enzyme and that the nucleotide effectors ATP, CTP and
UTP regulate the complex.
23































































































































































































Amino acid alignment of pyrI















































































































































   
   
   
   
   
   

































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   





















































































































































































































































































































































































































































Table 1.  Known pyrimidine genes in thermophilic organisms.
____________________________________________________________________
Organism pyrimidine genes organization of genes
____________________________________________________________________
M. jannaschii pyrB and pyrI genes separated by 200-kb
P. abyssi pyrB and pyrI genes are fused, one transcript
S. solfataricus pyrB and pyrI genes next to each other, not fused
S. acidocaldarius pyrB and pyrI genes separated by 1 bp
Ta. Maritime pyrB and pyrI genes are fused, one transcript
Thermus ZO5 pyrR-pyrB-bbc-pyrC genes in an operon





















































   
   

































































































































   







































































































































































Bacterial strains, plasmids, media and growth conditions.
The bacterial strains and plasmids used in this study are listed in Table 2.  The
genotype of Escherichia coli strain TB2 (argI -, argF - and pyrBI -) was confirmed by
checking for growth in E. coli minimal medium (Miller, 1992) with the addition of
arginine, uracil or both at a concentration of 50 µg ml-1.  For the transformation
experiments, the recombinant plasmids were selected on the appropriately
supplemented E. coli minimal medium.  Antibiotics were added at the following
concentrations: ampicillin 100 µg ml-1 and kanamycin 50 µg ml-1.  The carbon source
used was glycerol at 0.2%.  All E. coli TB2 strains harbouring the selected plasmids
were grown at 37◦C with shaking at 250 rpm.
Preparation of competent cells.
All E. coli TB2 competent cells for transformation experiments were prepared
using the calcium chloride method of Dagert & Ehrich (1979) with slight
modifications. The cultures were grown in 50 ml of E. coli minimal medium to an
optical density at 600 nm (OD600) of 0.2 to 0.4 and chilled on ice at 0 to 4◦C for 10
min.  The cells were harvested by centrifugation at 1875 xg at 4◦C for 15 min, the
pellet was resuspended in 20 ml of ice-cold 0.1 M CaCl2 and incubated on ice for 20
to 25 min.  The cells were centrifuged at 833 xg at 4◦C for 15 min, the pellet was
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resuspended in 0.7 ml of ice cold CaCl2 and incubated overnight on ice.  The
following day glycerol was added to a final concentration of 15% and the cells were
separated into 200 µl aliquots.  Cells were then frozen at 80◦C and could used for up
to three months.
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Table 2.  List of Strains and Plasmids
_____________________________________________________________________
Strain or Plasmid Genotype or relevant property
Strain
E. coli TB2 ΔpyrBI, arg I, argF
Plasmids
pUC18 pMB1 origin, high copy
pBJR28 E. coli pyrB
pEK2 E. coli pyrBI
pK184 Kanamycin resistant compatible plasmid
AMJAE67                              1.26 kb insert containing the M. jannaschii pyrI
                        gene in pUC18
AMJPK84                               1.2 kb insert containing the M. jannaschii pyrB
                                                gene in pUC18
pCRII vector                           Invitrogen linearized plasmid
pSPMI                                     Unmodified pyrI cloned into the EcoRI and
                                                 BamHI sites of pK184
pSPMI2                                 Shine Dalgarno and deletion of the first 3 amino
                                                acids cloned into pCRII vector
pSPMI3                                  Shine Dalgarno and change of the native GTG
                        start codon to an ATG start cloned into pCRII
                                                vector
pSPMI4                                 Shine Dalgarno and deletion of the first 3 amino
                                                acids cloned into pK184 vector
pSPMI5 Shine Dalgarno and change of the native GTG
                        start codon to an ATG start cloned into pK184
                                                vector
_____________________________________________________________________
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Transformation of E. coli TB2.
Transformation of E. coli TB2 with the plasmids  E. coli pyrB (pBJR28) (Fig
11), E. coli pyrBI (pEK2) (Fig 12) and M. jannaschii pyrB (AMJPK84) (Fig 13) were
conducted according the method described by Huff et al, (1990).  Approximately 40
ng of plasmid DNA were mixed with 200 µl of the CaCl2 treated cells and the mixture
was incubated on ice for 15 min.  The cells were then heat shocked at 42ûC for 2 min,
and then placed back into the ice bucket for a further 15 min.  One ml of LB broth
was added to the cells, which were then incubated at 37ûC for 1 h.  After 1 h the cells
were plated on LB medium, plasmid insertion was selected for by ampicillin
resistance at a concentration of 100 µg ml-1.
Further analysis was conducted to show that expression of the plasmid genes
satisfied the pyrimidine requirement of E. coli TB2.  The colonies that grew on the
LB ampicillin plates were replica plated onto three addition plates, of E. coli minimal
medium, of E. coli minimal medium supplemented with arginine and of E. coli
minimal medium plus arginine and uracil.  Untransformed E. coli TB2 cells were used
as a control.
Preparation of cell extracts for aspartate transcarbamoylase activity gels.
Starter cultures of cells containing the above plasmids pBJR28, pEK2,
AMJPK84 and E. coli TB2 with no plasmid were grown in 5 ml of E. coli  minimal
medium overnight with the addition of glucose as the carbon source, thiamine
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(vitamin B1), arginine, and ampicillin.  E. coli minimal medium (50 ml) with the
above additions was used and the starter cultures were used as the inoculum.  The
flasks were shaken at 37◦C at 250 rpm and grown to an OD600 of 0.5 to 0.7.  The cells
were harvested by centrifugation at 1875 xg at 4ûC for 15 min and resuspended in 1
ml of ATCase buffer (5 ml Tris-HCl pH 8.0, 200 µl 1M β-mercaptoethanol, 2 µl 1M
ZnSO4, 20 ml 100% glycerol and 75 ml ddH2O).  The cells were disrupted by
sonication for 3 min in an ethanol ice bath.  The sonicated extract was centrifuged at
12,000 xg at 4ûC for 30 min.  The supernatant (clarified extract) was transferred to a
sterile microcentrifuge tube and used to assay ATCase on an activity gel.
Heat treatment of clarified cell extract.
Thirty microliters (30 μl) of clarified cell extracts were heated at 65◦C and
80◦C for 0, 10, and 20, 30 min.  This part of the experiment was conducted in order to
test the thermostability and subunit structure of E. coli pyrB (pBJR28), E.coli pyrBI
(pEK2) and M. jannaschii pyrB (AMJPK84).  After the period of heat treatment, the
extracts were centrifuged at 10,000 xg for 1 min.  The clear supernatant was then used
for further analysis.
Non-denaturing polyacrylamide aspartate transcarbamoylase activity gels.
A nondenaturing polyacrylamide gel with 5% stacking gel and an 8%
separating gel was used.  The gel was prepared by first pouring the separation gel,
which contained 2.67 ml of the stock solution of acrylamide (30% w/v acrylamide and
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1 % w/v bis-acrylamide in ddH2O), 2.5 ml of Buffer B (1.5 M Tris-HCL, pH 8.8), and
4.83 ml of ddH2O.  Ammonium persulfate (0.02 g) was added to the mixture.  The gel
was polymerized with the addition of 5 µl of N, N, N N - tetramethylenediamine
(TEMED).  The mixture was gently inverted and poured into the assembled Bio-Rad
mini protean II apparatus.  A space of 2 cm was left at the top to pour the stacking gel.
The gel was overlaid with N- butanol to prevent drying and   was allowed to
polymerize for approximately 30 to 40 min after which the stacking gel was prepared.
The stacking gel contained 0.67 ml of acrylamide, 1 ml of buffer C (0.5 M Tris, pH
6.8) and 2.3 ml ddH2O, ammonium persulfate (0.01g) and 5µl of TEMED.  A 10 well
comb was inserted and the gel was allowed to polymerize.  16 µl of sample was
mixed with 5µl of 5X loading buffer (312.5 mM Tris, 50% v/v glycerol, and 0.05%
w/v bromophenol blue in ddH2O).  The samples were loaded onto the gel.  The
chamber was filled with gel running buffer (25 mM Tris, 192 mM glycine in ddH2O)
and electrophoresis was carried out 150 V for 1 h at room temperature.
Aspartate transcarbamoylase activity stain of the nondenaturing polyacrylamide
gels.
The gels were stained specifically for ATCase activity by the method
described by Bothwell (1975) as modified by Kedzie (1987).  The principle behind
method is that when ATCase catalyses the reaction between carbamoylphosphate and
aspartate to produce carbamoylaspartate, an inorganic phosphate is generated.  This
phosphate group reacts with lead nitrate to form a white precipitate.   A modified
version of the above method by Kedzie (1987) was performed.  The gels were placed
in 250 ml of 50 mM, histidine buffer pH 7.0 for 5 to 10 min that had been warmed at
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65ºC in a waterbath.  5 ml of 1 M aspartate and 10 ml of 0.1 M carbamoylphosphate
was added and the gels were incubated at room temperature on a rocking shaker.  The
reactants were removed by rinsing the gel in 100-200 ml of warm ddH2O 3 times.
Lead nitrate at a concentration of 3mM was added to another 250 ml of histidine
buffer, pH 7.0, which was then poured onto the gel.  After 10 min, the lead nitrate was
removed by washing three times in warm ddH2O.  ATCase activity was observed at
the site of lead phosphate precipitation.  The gel was left overnight at room
temperature to increase the visibility of the bands.  The gel was stained with 1%
sodium sulfate for 3 min and washed three times with ddH2O to convert the white
lead nitrate to black lead sulfide.  The gels were soaked in 10% glycerol and dried to
preserve them.
Cloning of the M. jannaschii pyrI gene into the compatible vector pK184.
The M. jannaschii pyrI (AMJE67) plasmid (Fig 14) was obtained from the
American Type Culture Collection (ATCC 623859).  In order to co-express this
plasmid with the M. jannaschii pyrB and with the E. coli pyrB gene (pBJR28) it was
necessary to clone it into the compatible plasmid pK184 (Fig 15) (GenBank accession
number U00800).  Plasmid pK184 DNA was digested with the restriction enzymes
EcoRI and Bam HI to linearize the plasmid and allow for the ligation of the M.
jannaschii pyrI gene fragment, which had been previously isolated from AMJE67
using the same enzymes.  The 1.26 kb pyrI gene fragment was purified from the
agarose gel using the Sephaglas Band Prep Kit® (Amersham-Pharmacia) and ligated
into pK184 to produce pSPM1 (Fig 16).
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Cotransformational studies using E. coli pyrB and M. jannaschii pyrI, and M.
jannaschii pyrB and M. jannaschii pyrI.
E. coli TB2 cells were transformed using the method described above.  DNA
from plasmids expressing the E. coli pyrB (pBJR28) and M. jannaschii pyrI (pSPMI),
M. jannaschii pyrB (AMJPK84) and pSPMI was used.  The insertion of both plasmids
was confirmed by extraction of plasmid using the alkaline lysis method.  The cell
extracts were run on 8% nondenaturing gels.  This experiment failed to produce a 310
kDa holoenzyme.
Addition of an E. coli like Shine Dalgarno sequence into the native M. jannaschii
pyrI by polymerase chain reaction.
Sequence analysis of the upstream DNA of the M. jannaschii pyrI did  not
reveal an E. coli consensus Shine Dalgarno sequence.  We also observed that 6 bases
in from the designated start there was another methionine residue which was coded
for by ATG.  Thus, 2 synthetic oligonucleotide primers were designed and
synthesized by of Biosynthesis, Inc.  The first primer was used to incorporate an E.
coli Shine Dalgarno (SD) sequence, as well to change the original GTG start codon to
an ATG start codon.  The second was used to incorporate an E. coli (SD) sequence
and delete the first three amino acids present in the native clone.  PCR using Taq
polymerase  (Saiki et al., 1998) was used to amplify the products (Table 3).  The
following conditions were used.    This enzyme generates 3T overhangs and this
allows for the direct cloning into the pCRTMII Vector (Fig 17) from The Original TA
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Cloning ® Kit (Invitrogen).  After ligation and transformation clones, which contained
the modification were selected on LB plus kanamycin 50 µg ml-1, with 5 bromo-4-
chloro-3-indolyl-β-D-galactoside (X-gal) at 0.003% and isopropyl-β-D-
thiogalactopyranoside (IPTG) at 0.03%.  White colonies appearing on the medium
were selected and grown in 5 ml of LB medium with 50 µg ml-1 of kanamycin.
Insertion of the modified pyrIs were confirmed by restriction digest and by DNA
sequencing.  The clones produced were termed pSPMI2 (addition of SD sequence
and deletion of the 1st 3 amino acids) and pSPMI3 (addition of an SD sequence and
change of the original GTG to and ATG start codon) (Fig 18 and 19).
Table 3   Oligonucleotides used for PCR of modified M. jannaschii pyrI
  Primer  Sequence (5- 3)             Use
MetIF  GGAGGAGAAATGTAACTATGATTCCTATGGAGGAGTTAAAA   SD sequence & GTG
                                                                                                        → ATG
MetIF   GGAGGAGAAATTAACTATGGAGGAGTTAAAAGTTAAAAAA    SD sequence &
     Deletion of First two
  amino acids
MetIR   TTTGAAATACTTCTTCCTTTAATTCCATAATACCA                       Reverse primer   
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DNA sequencing of pSPMI2 and pSPMI3
Sequencing of double-stranded DNA was performed with the Sequenase kit
(U.S. Biochemicals Corp.) based on the dideoxy method of Sanger et al., (1977 &
1980).  All reactions were carried out according to manufacturers specifications.
M13 20 forward primer and M13 reverse primer were used to sequence the
recombinant plasmids and confirm the orientation of the inserts.
Cloning of pSPMI2 and pSPMI3 into the compatible vector pK184
It was necessary to clone the modified pyrI genes, first into pUC19, and then
into pK184, due to the lack of enzymes that were available for the purpose of cloning
into pK184. Therefore, the insert from pSPMI2 and pSPMI3 was excised with the
restriction enzymes KpnI and XhoI.  The vector pUC19 was also digested with the
same enzymes and then a ligation reaction was set up.  E. coli DH5α was transformed
with the DNA.  Cells with the recombinant plasmids were selected on LB agar plates
with ampicillin at a concentration of 100 µg ml-1.  The plates also contained 5 bromo-
4-chloro-3-indolyl-β-D-galactoside (X-gal) at 0.003% and isopropyl-β-D-
thiogalactopyranoside (IPTG) at 0.03%.  Presumptive transformants containing the
insert appeared as white colonies and were picked.  Plasmid DNA was extracted using
the alkaline lysis method.
Upon confirmation of the insert of the appropriate size, by agarose gel
electrophoresis, the plasmid DNA was digested with the enzymes KpnI and SalI.  This
was also true of pK184.  Ligation of the modified pyrI genes with the compatible
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vector pK184 was set up.  E. coli DH5α cells were transformed and plated out on LB
agar with kanamycin at a concentration 50 µg ml-1.  The plasmids were named
pSPM4 (Fig 20) and pSPM5 (Fig 21).  The plasmids containing the inserts were
selected for cotransformational studies along with M. jannaschii pyrB (AMPK84).
Cotranformational studies with the various modified M. jannaschii pyrI plasmids
and the M. jannaschii pyrB plasmid.
E. coli TB2 cells were transformed with the above plasmids.  Table 4 lists the
plasmids.  The insertion of both plasmids was confirmed by isolation of plasmid
DNA.  Cell extracts were prepared for ATCase activity gels as described earlier.
Clarified cell extracts were heated at 80○C for 20 min before loading onto






AMPK84 + pSPMI2 M. jannaschii pyrB and modified pyrI in pCRII
vector
AMPK84 + pSPMI3 M. jannaschii pyrB and modified pyrI  in pCRII
vector
AMPK84 + pSPMI4 M. jannaschii pyrB and modified pyrI in pK184
vector




Effector response of 310 kDa Aspartate Transcarbamoylase of M. jannaschii.
Cell extract was assayed for ATCase activity by measuring the amount of
carbamoylaspartate (CAA) produced at 20 min at 37°C.  The method used was the
color reaction described by Prescott & Jones, 1969.  ATCase assays were performed
to determine the Vmax, KM and nucleotide effector response.  A tribuffer system (0.05
M MES, 0.1 M diethanolamine, and 0.051 M N-ethymorpholine) was used.  The
assay was conducted at pH 9.5 in a microtiter plate.  Aspartate was varied from a final
concentration of 5 mM to 60 mM and carbamoylphosphate was kept at a
concentration of 5 mM.  The total volume of the assay was 200 μl.  Effector response
could be measured by adding UTP, CTP, or ATP at a final concentration of 1 mM
into the microtiter plate wells.  A blank control containing all ingredients minus the
enzyme was used.  This reading was then subtracted from the final reading for the
experimental reaction.  An aliquot of the enzyme was incubated at 80ºC and then 1 μl
of it was used in the reaction.  The assay reaction plate was preincubated at 37ºC for 2
to 3 min.  The reaction was initiated with the addition of cabamoylphosphate.  At 20
min the reaction was stopped with the addition of 100 μl of stop mix (2 parts
antipyrine (5 mg/ml) in 50% sulfuric acid and 1 part monoxime (8 mg/ml) in 5 %
acetic acid).  After the addition of the stop mix clear tape was applied to the top of the
wells to prevent the evaporation of the reaction mixture.  The color was developed at
60ºC in a waterbath.  The assay was read at 450 nm in a kinetic microplate reader by
molecular devices.  Velocity substrate curves were generated by plotting the specific
activity of the enzyme (μmol CAA/min/μg of protein).  The protein concentration was
measured by the method described by Bradford  (1976) with Bovine Serum Albumin
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as the standard.  The μmol produced was calculated by generating a CAA standard
curve.
In vitro expression of modified PyrI from M. jannaschii.
The M. jannaschii PyrI protein was expressed using the E. coli  S30 extract for
Circular DNA (Promega).  This procedure allows one to observe the transcription and
translation of DNA sequences that have been cloned into plasmid vectors.  The
technique is based on the method described by Zubay (1973) and allows for the
characterization of polypeptides from cloned genes.
One μg of pSPMI4 and pSPMI5 DNA (individually) was used as the template.
The DNA was mixed with 5 μl of amino acid mixture, which was devoid of
methionine, 20 μl of s30 Premix without amino acids, 15 μCi of [35 S] methionine
(NEN Dupont) and 15 μl of s30 Circular extract.  Nuclease-free water was added to a
final volume of 50 μl.  The components were mixed by vortexing and then
centrifuged at 12,000 xg for 5 s to collect the mixture at the bottom of the tube.  The
reaction was incubated at 37○C for 2 h.  The reaction was terminated after 2 h by
placing the tubes on ice for 5 min.  A 5 μl aliquot was transferred to a fresh tube and
was precipitated by adding 20 μl of acetone.  This step removes the polyethylene
glycol (PEG) present in the reaction mixture.  The supernantant was aspirated and the
pellet was dried for 15 min in a vacuum desiccator.  The expressed proteins were
analysed by sodium dodecyl sulfate polyacrylamide gel electrophoresis.  The proteins
were then visualized by autoradiography.
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Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
SDS is an anionic detergent, which denatures proteins by binding or wrapping
around the protein backbone.  The method denatures the protein into its individual
subunits and thus separates them based on their molecular weight.  SDS binds
specifically to proteins and confers a negative charge to them.  It is necessary to
reduce the disulfide bridges in proteins so that they would adopt a random coil
configuration.  This allows for the proteins to be separated based on its molecular
weight.  Therefore separation of proteins using SDS-PAGE is determined by
molecular weight rather than its intrinsic electrical charge.  A 15% SDS
polyacrylamide separating gel with a 5% stacking gel was used to analyze the
samples.  The apparatus used to conduct the electrophoresis was the Mini-Protean
II chamber (Bio-Rad).
The gel was prepared by first pouring the 15% separating gel, which contained
5 ml of the stock solution of acrylamide (30% w/v acrylamide and 0.8 % w/v bis-
acrylamide in ddH2O), 2.5 ml of Buffer B (1.5 M Tris-HCl, pH 8.8, 0.4% w/v SDS in
ddH20), and 2.5 ml of ddH2O.  Ammonium persulfate (0.02 g) was added to the
mixture and mixed by vortexing gently to dissolve the ammonium persulfate.  The gel
was polymerized with the addition of 5 µl of N, N, N N - tetramethylenediamine
(TEMED).  The mixture was gently inverted and poured into the assembled apparatus.
A space of 2 cm was left at the top to pour the stacking gel.  The gel was overlaid
with n - butanol to prevent drying and was allowed to polymerize for approximately
30 to 40 min after which the stacking gel was prepared.  The stacking gel contained
0.67 ml of Solution A, 1 ml of buffer C (0.5 M Tris, pH 6.8, 0.4% w/v SDS) and 2.3
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ml ddH2O, ammonium persulfate (0.01 g) and 5 µl of TEMED.  A 10 well comb was
inserted and the gel was allowed to polymerise for 1 h.  The gel was placed into the
apparatus and the tank filled up with denaturing gel running buffer (25 mM Tris, 192
mM glycine and 0.1% SDS w/v, pH 8.3).   The sample were mixed at a ratio of 4:1
with the gel loading dye (60 mM Tris-HCI, pH 6.8, 25% glycerol v/v, 2% SDS w/v,
14.4 mM β-mercaptoethanol, 0.1% Bromophenol blue) in a sterile microfuge tube.
The samples and the standards were boiled for 2 min and cooled on ice.  The samples
and the standards were loaded onto the gel and electrophoresed for 90 min at 150 V.
The proteins were stained with Coomasse Blue staining solution (45% methanol v/v,
10% acetic acid v/v, 0.1% Coomasse Brilliant Blue R-250 w/v in ddH2O) for 10 min
with gentle rocking.  The gel was destained with a solution of 10% methanol v/v and
10% glacial acetic acid v/v in ddH2O for 3 h.  The gel was dried on a Whatmann








Fig 11.  Plasmid  pBJR28 constructed by Jill Ruley.  The plasmid contains the entire










Fig 12.  Schemmatic representation of plasmid pEK2.  The plasmid contains the entire








AMJPK84 M. jannaschii pyrB
3733 bp
Fig 13.  Plasmid AMJPK84 containing the intact 1.2 kb M. jannaschii pyrB gene in








AMJE67 M. jannaschii pyrI
3623 bp
Fig 14.  Plasmid AMJ67 containing the entire 1.26 kb M. jannaschii pyrI gene in
pUC18.  Plasmid was obtained from the American Type Culture collection (ATCC
623859).
49










Fig 16.  The M. jannaschii 1.26 kb pyrI gene fragment from AMJE67 cloned into the
pK184 plasmid at the EcoRI and BamHI restriction sites




































Fig.18 Schematic diagram of the pCRII vector harbouring the modified M. 
jannaschii pyrI.  Addition of an E. coli like Shine Dalgarno change of the native 















Fig.19 Schematic diagram of the pCRII vector harbouring the modified M. jannaschii
















Fig. 20 Schematic diagram of recombinant plasmid containing the modified M.
jannaschii pyrI subcloned from pUC19 into pK184.  The insert size is 576-bp and 
contains the modified pyrI native sequence.  Shine-Dalgarno sequence has been 
added and the native GTG start codon changed to ATG.  
   R
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Fig. 21  Schematic diagram of recombinant plasmid containing the modified M. 
jannaschii pyrI subcloned from pUC19 into pK184 plasmid.  The insert size is 
568-bp and contains the modified pyrI native sequence.  Shine Dalgarno added and 






Cell extracts from E. coli TB2 cells containing various plasmids were run on
ATCase activity gels (Fig 21).  E. coli TB2 cells containing the E. coli pyrBI from
expressed from the plasmid pEK2 showed aggregated forms of ATCase and bands
corresponding to 310 kDa and 270 kDa.  Cells containing the E. coli pyrB only (pBJR28)
showed a 100 kDa ATCase band corresponding to the catalytic pyrB trimer.  Cells
containing the M. jannaschii pyrB gene (AMJPK84) similarly showed the 100 kDa
ATCase band corresponding to the catalytic trimer.
(4&-/.+#*5$2$#6'.,'*"#$%&'!()*+&'&7".3&3'56'E. coli pyrB'819:;<=>?'E. coli pyrBI
81@A<>'*73'M. jannaschii pyrB'8!B:CA=D>'*#'EFG)H
The thermostability of the E. coli ATCase was compared to that of M. jannaschii.
E. coli TB2 cells containing the plasmids pBJR28 (E. coli pyrB), pEK2 (E. coli pyrBI)
and AMJPK84 (M. jannaschii pyrB) were grown at 37○C.  30 μl of clarified cell extracts
were heated at 65○C for 0, 10, 20 and 30 min.  ATCase activity gels showed that the E.
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coli enzyme remained fully active after the heat treatment.  E. coli TB2 cells containing
the pBJR28 plasmid showed 100 kDa ATCase bands up to 30 min of incubation at 65○C.
At time 0 the E. coli TB2 cells containing the pEK2 plasmid showed a holoenzyme at 310
kDa.  The 310 kDa holoenzyme form disappeared after heating presumably degrading
into the catalytic trimer form as the incubation time increased.  In contrast the E. coli TB2
sample containing the M. jannaschii pyrB gene showed very little or no activity at time 0
(no heat treatment).  As the sample was incubated at 65○C the ATCase seemed to become
active and its activity increased as the incubation time increased (Fig 22).  This result
suggests that the E. coli enzyme is sensitive to temperature and the enzyme is less active
at higher temperatures.  The M. jannaschii catalytic subunit responds to high
temperatures and therefore is more thermostabile.
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     1                                           2                                    3
Fig 21.  ATCase expressed from various plasmids.  Lane 1. The E. coli pyrBI gene
products showing the aggregated form of ATCase along with the 310 kDa (2C3:3R2), the
270 kDa (2C3:2R2), and the 100 kDa (C3) forms.  Lane 2 shows the E. coli pyrB gene




Fig 22a.  Thermosensitivity of ATCase expressed from plasmids pEK2 and pBJR28 in E.
coli TB2.  Cell extracts were heated to 65°C and loaded onto the gel.  Lanes
1-4. E. coli pyrB (pBJR28) incubated at 65°C for 0, 10, 20, and 30 min, respectively.
Lanes 5-8. E. coli pyrBI (pEK2) incubated at 65°C for 0, 10, 20, and 30 min.
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Fig 22b.  Thermostability of E. coli TB2 cells harboring the M. jannaschii pyrB
(AMPK84) plasmid.  Cell extracts were heated at 65°C.  Lane 1 heat treatment for 0 min.
Lane 2 heat treatment for 10 min.  Lane 3 heat treatment for 20 min.  Lane 4 heat
treatment for 30 min.
IJJ KL*
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(4&-/.+#*5$2$#6'.,'*"#$%&'!()*+&',-./'E. coli pyrB'819:;<=>?'E. coli pyrBI'81@A<>
*73M. jannaschii pyrB'8!B:CA=D>'*#'=JO)H
The various protein products expressed from plasmid DNAs expressed in E. coli
TB2 were incubated at 80○C for 0, 10, 20 and 30 min.  Results from this experiment
showed that the E. coli pyrB and E. coli pyrBI expressed form the plasmids containing
cell extract are denatured with heat
(Fig 23).  The lanes on the activity gel containing the E. coli pyrB expressed product and
E. coli pyrBI gene product samples showed no ATCase activity and this suggests that the
E. coli enzyme is very sensitive to high heat.  In contrast the M. jannaschii pyrB gene
product retained activity after heating at 80○C for 30 min.
At high temperatures, pyrimidine biosynthesis is confronted with the
thermostability of not only the enzymes of the pathway but also with the stability of the
substrates.  One of the ATCase substrates, carbamoylphosphate, is thermolabile with a
half-life of 30 min at 37○C.  At higher temperatures such as 80○C the half-life is reduced
dramatically.  Thus microorganisms grow optimally at high temperatures must have
developed a strategy to utilize the CP very quickly.  One of the mechanisms of protecting
CP at 100○C is involves its rapid conversion to a heat stable compound such as
carbamoylasaprtate, dihydroorotate or orootate.  This could then satisfy pyrimidine and
arginine biosynthesis (Purcarea., 1996).
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Fig 23.  Thermostability of ATCase encoded by E. coli pyrB (pBJR28), E. coli pyrBI
(pEK2) and M. jannaschii pyrB (AMPK84).  Lane 1. E. coli TB2 cell extract harboring
plasmid AMPK84, 10 min of incubation at 80ûC.  Lane 2. E. coli TB2 harboring plasmid
AMPK84, 20 min of incubation at 80ûC.  Lane 3. E. coli TB2 harboring plasmid
AMPK84, 30 min.  Lane 4.  E. coli TB2 harboring plasmid pBJR28, 30 min.  Lane 5.  E.
coli TB2 harboring plasmid pBJR28, 20 min.  Lane 6.  E. coli TB2 harboring plasmid
pBJR28, 10 min.  Lane 7. E. coli TB2 harboring plasmid pEK2, 30 min.  Lane 8.  E. coli




E. coli TB2 cells were transformed with the previously described plasmids.  Pairs
of plasmids were cotransformed (Table 4).  The recombinants were able to satisfy the
pyrimidine requirement of E. coli TB2.  The insertion of both plasmids was confirmed by
isolation of plasmid DNA.  Cell-free extract was prepared as described in the materials
and method section.  Clarified cell extract was heated for 20 min at 80○C and loaded onto
a non-denaturing ATCase activity gel.  The results from this experiment show that the
ATCase from M. jannaschii is capable of assembling into a 310 kDa E. coli-like
holoenzyme
(Fig 24).  The plasmid that was constructed by altering the original GTG start codon to an
ATG start was able to produce a 310 kDa enzyme.  A similar result was observed with
the recombinant plasmid where the second internal methionine (ATG) was used instead
of the designated methionine (GTG).
 Kantrowitz and coworkers (1999) showed that only the M. jannaschii pyrB gene
product exhibited catalytic activity as trimer and that the M. jannaschii pyrI gene product
existed as a dimer.  Preliminary characterization of the enzyme conducted by the above
researchers suggested that the enzyme was similar to the E. coli ATCase with regard to
the molecular mass.  However in this paper no data upholding the suggestion was
presented.  Here I present data that shows the M. jannaschii ATCase is capable of
assembling into a 310 kDa ATCase.
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Fig 24.  Nondenaturing polyacrylamide gel stained for ATCase activity.  Lane 1, Purified
E. coli holoenzyme.  Lane 2, E.coli pyrB gene product.  Lane 3, M. jannaschii pyrB gene
product.  Lane 4, M. jannaschii pyrB + M. jannaschii pyrI gene products.  Lane 5 M.
jannaschii pyrB + M. jannaschii pyrI’ gene products.  Lane 6, M. jannaschii pyrB + M.
jannaschii pyrI gene products.  Lane 7, M. jannaschii pyrB + M. jannaschii pyrI’ gene





ATCase assays were performed to determine the Vmax, KM and nucleotide effector
response for the M. jannaschii pyrB and the two genetically modified pyrIs.  Partially
purified cell sonicates were assayed for ATCase activity by measuring the amount of
CAA produced at 37°C for 20 min using the colorimetric method described by Prescott
& Jones 1969.  The assay was conducted in a microtiter plate and the absorbance was
read at 450 nm in a kinetic microplate reader.
The KM for aspartate was calculated to be 20 mM in both of the cases (Figs 26 & 29).  It
was also observed that the KM for carbamoylphosphate was in accordance with findings
in 1999 at 88 μM of CAA min-1 (data not shown).
In contrast to their data we observed regulation of the ATCase by nucleotide
effectors.  For the M. jannaschii pyrB and the pyrI where the GTG start codon was
changed to an ATG start codon along with the addition of an E. coli like Shine Dalgarno
no regulation by the nucleotides UTP, ATP and CTP was observed (Fig 28).  However
we did assemble a 310 kDa holoenzyme.
When an E. coli Shine Dalgarno was added along with the removal of the 1st 3
amino acids we observed regulation of the ATCase enzyme by the nucleotide effectors
UTP, CTP and ATP.  At low aspartate concentration (05 mM) and saturating
carbamoylphosphate (5 mM) CTP, ATP and UTP inhibited the activity of ATCase.  At
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saturating levels of aspartate (40-60 mM) enzyme activity was activated by CTP and
ATP and slightly inhibited by UTP (Fig 30).
The native pyrI start codon was designated by GenBank to be a GTG start because of the
alignment with the amino acids sequence of E. coli.  However if one looks at the amino
acid alignment (Fig 10) it can be seen that a second methionine is preceded by the amino
acids methionine, isoleucine and proline in the order of MIPM.  It is our belief that the
internal methionine is in-fact the correct start for the M. jannaschii pyrI gene which
would make perfect genetic sense when one considers the G + C content of 31% for M.
jannaschii.  Other researchers have used the 1st methionine as the proposed start and
appear to have failed in their endeavors to see regulation of the M. jannaschii ATCase

























































































































































































































































































































































































































































































































































































































































































































































































The M. jannaschii PyrI protein was expressed using the E. coli S30 extract.  This
procedure follows the basic method described by Zubay in 1973.  The procedure allows
one to directly observe the transcription and translation of specific DNA sequences and
thus allows for the characterization of polypeptides from specific genes.  In this case the
two clones described earlier as pSPMI4 and pSPMI5 were used with one μg of plasmid
DNA in each case.  A 15% SDS gel was used to determine the molecular weight of the
M. jannaschii PyrI protein.  Results from this experiment showed the formation of a 17
kDa polypeptide from each of the plasmids (Fig 31a).  The native size of the polypeptide
is 34 kDa as observed in figure 31b from the same plasmids.
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Fig 31a & 31b. Zubay analysis of M. jannaschii modified pyrI clones.   Figure 31a shows
the results of a 15% SDS PAGE gel.  Lane 1 shows the product of the plasmid pSPMI5
and lane 2 shows the product of the plasmid pSPMI4.  Both recombinant plasmids
showed the formation of a 17kDa protein product.  Figure 31b shows the results of a 15%
native gel.  Lane 1 shows the 34 kDa subunit size from the plasmid pSPMI4 M.







1. Adair, L. B. & Jones, M. E.  1972.  Purification and characteristics of aspartate
transcarbamoylase from Pseudomonas flourescens. J Biol Chem. 247, 2308-2315
2. Beckwith, J. R., Pardee, A. B., Austrain, R., & Jacob, F. 1962.  Coordination of the
synthesis of the enzymes in the pyrimidine pathway of E. coli. J Mol Biol 5, 618-634.
3. Bergh, S. T., & Evans, D. R. 1993.  Subunit structure of Class A aspartate
transcarbamoylase from Pseudomonas flourescens. Proc. Natl. Acad. Sci. USA 90:
9819-9822.
4. Bethell, M. R., & M. E. Jones. 1969. Molecular size & feedback regulation
characteristics of bacterial aspartate transcarbamoylases. Arch. Biochem. Biophys. 134:
352-356.
5.  Bothwell, M. 1975 Ph.D. Thesis.  University of Calfornia, Berkeley.
6. Bult, C. J., O. White, G. J. Olsen, L. Zhou, R. D. Fleischmann, G. G. Sutton, J. A.
Blake, L. M. FritzGerald, R. A. Clayton, J. D. Gocayne, A.R. Kerlavage, B. A.
Dougherty, J. F. Tomb, M. D. Adams, C. I. Reich, R. Overbeek, E. F. Kirkness, K.
G. Weinstock, J. M. Merrick, A. Glodek, J. L. Scott, N. S. M. Geohagen, J., & C.
Venter.  1996. Complete genome sequence of the methanogenic archaeon,
Methanococcus jannaschii. Science 23; 273 (5278): 1058-73.
76
7. Caroline, D.F. 1969.  Pyrimidine synthesis in Neurospora crassa: gene-enzyme
relationships. J Bac. 100, 1371-1377.
8. Condon, S., Collins, J. K. & ODonovan, G. A. 1976.  Regulation of arginine and
pyrimidine biosynthesis in Psedomonas putida. J. Gen Microbiol. 92, 375-383.
9. Cunin, R. 1997. Carbamoylphosphate metabolism in thermophiles and
hyperthermophiles- a perspective.  Paths to Pyrimidines. 5. 37-50.
10. Dagert , M. & Ehrich, S. D. 1979.  Prolonged incubation in calcium chloride
improves the competence of Escherichia coli. Gene 6, 23-28
11. Foltermann, K.F., Wild, J.R., Zink, D.L. & ODonovan, G.A. 1981.
12. Gerhart, J. C. & Pardee, A. B. 1962.  The enzymology of control by feedback
inhibition. J. Biol Chem 237, 891-896.
13. Gerhart, J. C. & Pardee, A. B. 1964.  Aspartate transcarbamoylase, an enzyme
designed for feedback inhibition.  Fed Proc 23, 727-735.
14. Grogan, D.W. & Gunsalus, R. P. 1993. Sulfolobus acidocaldarius synthesizes
UMP via a standard de novo pathway: Results of a biochemical-genetic study.  J Bac.
175, 1500-1507.
15. Hager, S. E. & Jones, M. E. 1967.  A glutamine dependent enzyme for the synthesis
of carbamoylphosphate in fetal rat liver.  J Biol Chem. 242, 5674-5680.
16. Hayward, W. S. & Bessler, W. L. 1965.  Regulation of pyrimidine biosynthesis in
Serratia marcescens. Proc Natl Acad Sci USA 53, 1483-1489.
17. Huff., J. P., Grant., B. J., Penning., C. A. & Sullivan, K. F. 1990.  Optimization of
transformation of Escherichia coli with plasmid DNA. Biotechniques 9: 570-577.
77
18. Hughes, L. E, Hooshdaran, M. Z, & O Donovan, G. A. (1999). Streptomyces
aspartate transcarbamoylase is a dodecamer with dihdroorotase activity.  Cur Micro. 39.
175-179.
19. Hutson, J. Y. & Downing, M. 1968.  Pyrimidine biosynthesis in Lactobacillus
leichmannii. J. Bac. 96, 1249-1254.
20. Isaac, J. H. & Holloway, B. W. 1968.  Control of pyrimidine biosynthesis in
Pseudomonas aeruginosa. J Bac. 96, 1732-1741
21. Jones, M. E. 1980.  Pyrimidine nucleotide biosynthesis in animals: genes, enzymes
and regulation of UMP biosynthesis.  Ann Rev Biochem 49, 253-279.
22. Jones, W. J., J. A. Leigh, F. Mayer, C. R. Woese, & R. S. Wolfe. 1983.
Methanococcus jannaschii SP. Nov, An extremely thermophilic methanogen from
submarine hydrothermal vent. Arch. Microbiol. 136: 254-261.
23. Kafer, C. & Thornberg, R. W. (1999).  Pyrimidine metabolism in plants.  Paths to
pyrimidines, 5. 7-19.
24.  Kedzie, K. M. 1987.  Ph.D. dissertation.  Texas A & M University, College station.
25. Lacroute, F. 1968.  Regulation of pyrimidine biosynthesis in Sacharomyces
cerevisiae. J Bac. 95, 824-832
26. Lerner, C. G., & Switzer, R. L. (1987).  Cloning and structure of the Bacillus
subtilis aspartate transcarbamoylase gene (pyrB). J Biol.Chem. 261: 11156-11165
27. Linscott A., J. 1996.  Regulatory divergence of aspartate transcarbamoylase from
the Pseudomonads.  Ph.D dissertation (Biology).  University of North Texas.
78
28. Long, C. & Koshland, Jr., D. E. 1978.  Cytidine triphosphate synthetase.  Methods
Enzymol 51, 79-83.
29. Long, C. and Pardee, A. B. 1967.  Cytidine triphospahte synthetase of Escherichia
coli B. I. Purification and kinetics. J. Biol Chem. 242, 4715-4721
30. Lu, Y., Turner, R. L. & Switzer, R. L. 1995.  Roles of three transcriptional
attenuators of the Bacillus subtilis pyrimidine biosynthetic operon in the regulation of its
expression.  J Bac. 177, 1315-1325.
31. Lu, Y. & Switzer R. L. 1996.  Evidence that the Bacillus subtilis pyrimidine
regulatory protein PyrR acts by binding to pyr mRNA at three sites in vivo.  J Bac. 178,
5806-5809.
32. Miller, J. H. (1992).  Experiments in molecular genetics, p432.  Cold Spring Harbor
Laboratory, Cold Spring Harbor, NY.
33. Nakinishi, S., Ito, K. & Tatibana, M. 1968.  Two types of carbamoylphosphate
synthetase in rat liver: chromatographic resolution and immunological distinction.
Biochem Biophys Res Comm 33, 774-781.
34. Navre M.& Schachman, H. K. (1983).  Synthesis of asaprtate transcarbamoylase in
Eschericia coli: transcription regulation of the pyrBI operon.  Proc Natl Acad Sci.  USA
80. 1207-1211
35. O' Donovan, G. A., Herlick, S., Beck, D. E., & Dutta, P. K.,  1989.  UTP/CTP
ratio, an important regulatory parameter for ATCase expression.  Arch Microbiol 153,
19-25.
79
36. O Donovan, G. A. & Shanley, M. S. 1995.  Pyrimidine metabolism in
Pseudomonas. Paths to pyrimidines 3, 49-59.
37. Patel, M. V. (2001)  The regulatory roles of pyrR and crc in pyrimidine metabolism
in Psedomonas aeruginosa.  Ph.D dissertation (Biology).  University of North Texas
38. Prescott, L. M., & Jones, M. E.  1969.  Modified methods for the determination of
carbamoylaspartate.  Anal. Biochem. 32, 408-419.
39.  Purcarea, C., Erausa, G., Prieur, D., & Herve, G.  (1994).  The catalytic and
regulatory properties of aspartate transcarbamoylase from Pyrococcus abyssi a new deep-
sea hyperthermophillic archaeo-bacterium.  Microbiology. 140: 1967-1975.
40. Purcarea, C., Herve, G., Ladjimi, M. M., & Cunin, R.  1997. Aspartate
transcarbamoylase from the deep-sea archaeon Pyrococcus abyssi:  Genetic organization,
structure and expression in Escherichia coli. J. Bac. 179: 13 4143-4157.
41. Roof , W. D., Foltermann, K. F., & Wild, J. R.  1982.  The organization and
regulation of the pyrBI operon in Escherichia coli includes a rho-independent attenuator
sequence. Mol. Gen. Genet. 187, 91-400.
42.  Saiki, R. K., Gelfland, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Harn, G. T.,
Mullis, K. B. & Erlich, H. A. 1986.  Primer-directed enzymatic amplification of DNA
with a thermostable DNA polymerase.  Science 239, 487-491.
43. Sanger, F., Nicklen, S. & Coulson, A. R. 1977.  DNA sequencing with chain-
terminating inhibitors.  Proc Natl Acad Sci USA 74, 5463-5467.
44.  Schurr, M. J., Vickery, J. F., Kumar, A. P., Campbell, A. L., Cunin, R.,
Benjamin, R. C., Shanley, M. S. & ODonovan, G. A. 1995.  Aspartate
80
transcarbamoylase genes of Pseudomonas putida.  Requirement for an inactive
dihydroorotase for assembly into the dodecameric holoenzyme.  J. Bac. 117, 1751-1759.
45.  Stryer, L.  1995. Biochemistry, 4th Edition.  W. H. Freeman and Company, New
York.  Pg 745-748.
46. Switzer, R. L., Turner, R. J. &  Lu, Y. 1999.  Regulation of the Bacillus subtilis
pyrimidine operon by transcriptional attenuation: control of gene expression by an
mRNA-binding protein.
47. Turnbough, C. L., Hicks, K.L., &  Donahue, J. P.  1983.  Attenuation control of
pyrBI operon expression in Escherichia coli K-12. Proc. Natl. Acad. Sci. USA, 80, 368-
372.
48. Turner, R. J., Bonner, E. R., Grabner, J. K. & Switzer, R. L. 1998.  Purification
and the characterization of Bacillus subtilis PyrR, a bifunctional pyr mRNA-binding
attenuation protein/uracil phosphoribosyltransferase.  J Biol chem. 273, 5932-5938.
49.  Van de Casteele, M., Chen, P., Roovers, M., Legrain, C.,  & Glansdorff, N.
1997. Structure and expression of a pyrimidne gene cluster from the extreme
thermophile Thermus strain ZO5.  J Bac. 179: 3470-3481.
50. Vickrey, J. F. (1993).  Isolation and characterization of the operon containing
aspartate transcarbamoylase and dihydrooratase from Pseudomonas aeruginosa.  Ph.D
dissertation (molecular biology), University of North Texas.
51. Yan, Y. & Demerec, M. 1965.  Genetic analysis of pyrimidine mutants in
Salmonella typhimurium. Genetics 52, 643-651
81
52. Yates, R. A., and Pardee, A. B.  1956a.  Pyrimidne biosynthesis in Escherichai coli.
J Biol. Chem. 221, 743-756.
53.  Yates, R. A., and Pardee, A. B.  1956b.  Control of pyrimidine biosynthesis in
Escherichia coli by feedback-mechanism.  J Biol. Chem. 221, 757-770.





The genus Pseudomonas is defined as having unicellular straight Gram negative
rods.  With the exception Pseudomonas mallei, all species are motile with one or more
polar flagella.  The G + C content of the pseudomonads is 58% to 69% (Mandel, 1966).
Pseudomonads have an oxidative metabolism and all pseudomonads lack the
enzyme phosphofructokinase.  Therefore they cannot utilize the Embden-Meyerhof
glycolytic pathway (Entner & Doudoroff, 1952; Conway, 1992).  Instead pseudomonads
use the Entner-Doudoroff pathway to form pyruvate from carbohydrates.  Glucose is
converted to glucose-6-phosphate by glucokinase encoded by glk.  Glucose-6-phosphate
is further metabolized to 6-phosphogluconate by the product of the zwf gene, which
encodes glucose-6-phosphate dehydrogenase.  Two enzymes specific to ED convert 6-
phosphogluconate to 2-keto-3-deoxy-6-phosphogluconate.  Aldolase encoded by eda then
catalyzes the formation of pyruvate and glyceraldehydes-3-phosphate.  The two products
can then be further metabolized via the EMP glycolytic pathway and the tricarboxylic
acid cycle (TCA).
The genus Pseudomonas includes the opportunistic human pathogen
Pseudomonas aeruginosa. P. aeruginosa is a ubiquitous environmental bacterium first
named by Migula in the early 1900.  P. aeruginosa is versatile in that it can grow at
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temperatures of 4ûC to 43ûC and the bacterium can grow in many different environments
such as  soil, marshes, marine environments, plants and animal tissue.  Pigment
production by P. aeruginosa is a key identification factor for this organism.  Pyocyanin is
a blue-green pigment, which is unique to this speciesmicroorganism.  Other pigments
such as pyoverdin (yellow), pyorubin (red) and pyomelanin (brown) are also produced by
this organism.  The pigment production is an iron scavenging mechanism from the
surrounding medium and these pigments also act as virulence factors.  Scientific evidence
is also emerging that the production of pigment is linked to the pyrimidine biosynthetic
pathway.
P. aeruginosa is a human pathogen because of its resistance to certain antibiotics
and disinfectants, which would eliminate other bacterial species.  P. aeruginosa is a
common source of bacteraemia in burn victims, urinary tract infections in patients who
are catheterized, cancer patients and AIDS patients (Stover et al., 2000).  It does not
usually cause disease in healthy individuals but is very persistent in immunosuppressed
persons.
Cystic fibrosis (CF) is an autosomal recessive disorder, which is prevalent in
approximately 1 in 2,500 live births.  The prevalence of this disease amongst Caucasian
populations is very high and is characterized by the excessive mucus production in the
lungs of affected individuals.  The excess mucus build up in (CF) patients is a perfect
environment for P. aeruginosa to colonize.  Thus P. aeruginosa is a major cause of
morbidity and mortality in CF patients, usually due to the lack of effective antibiotics
available to treat the infection.  Death of the patient occurs due to pulmonary failure.
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Pyrimidine biosynthesis.
Pyrimidine and purines are essential for the building materials ribonucleic acid
(RNA) and deoxyribonucleic acid (DNA). These molecules are required for the passage
of genetic information to succeeding generations in bacteria, fungi, plants and mammals.
Therefore the study of the synthesis of these macromolecules is imperative if one is to
understand evolutionary relationship between the three domains of life.  Two pathways
form pyrimidine ribonucleotides, the de novo and the salvage pathway.
The pyrimidine biosynthetic pathway has been studied in detail in bacteria (Yates
& Pardee, 1956a, 1956b, 1957; Beckwith et al., 1962; Hayward & Besler, 1965; Yan &
Demerec, 1965; Hutson & Downing, 1968; Isaac & Holloway, 1968; Condon et al.,
1976, Foltermann et al., 1981; Grogan & Gunsalus, 1993), fungi (Lacroute, 1968;
Caroline, 1969), plants (Kafer & Thornburg, 1999) and mammals (Hager & Jones, 1967;
Nakinishi et al., 1968; Jones, 1980).
There are nine enzymatic steps, which ultimately result in the formation of the
pyrimidine ribonucleotides UTP and CTP (Fig 2).  The pyrimidine ring is assembled first
and then linked to ribose phosphate to form the initial pyrimidine nucleotide OMP.  The
precursors of the pyrimidine ring are carbamoylphosphate and aspartate. The initial step
in the pathway is the formation of carbamoylphosphate, which is produced in the reaction
catalyzed by carbamoylphosphate synthetase (CPSase; carbamoylphosphate: L-aspartate
carbamoyltransferase, EC 6.3.55).  Carbamoylphosphate plays a dual role, being required
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not only for pyrimidine but also for arginine biosynthesis.   The carAB genes encode
CPSase in Escherichai. coli.
The next step in the pathway involves the carbamoylation of aspartate by
aspartate transcarbamoylase (ATCase; EC 2.1.3.2) to form N-carbamoylaspartate and
inorganic phosphate.  This reaction is the first committed step in the synthesis of
pyrimidine nucleotides de novo.  The genes encoding ATCase in E. coli are pyrBI and in
Pseudomonas are pyrBC' .
Carbamoylaspartate cyclizes with the loss of water to yield dihydroorotate.  At
this stage the pyrimidine ring has formed.  The reaction is catalyzed by dihydroorotase
(DHOase; EC 3.5.2.3), encoded by the pyrC gene.  The dihydroorotate so formed is then
oxidized to orotate by dihydrooorotate dehydrogenase (DHOdehase; EC 1.3.3.1),
encoded by pyrD.  DHOdehase is a flavoprotein which is membrane associated.
The next step in the pathway involves the acquisition of a ribose phosphate group.
Orotate phosphoribosyltransferase (OPRTase; EC 2.4.2.10) catalyzes the reaction where
orotate a free pyrimidine, reacts with PRPP to yield orotidine-5-monophosphate (OMP)
and pyrophosphate.  This reaction is driven forward by the hydrolysis of pyrophosphate.
The pyrE gene encodes the enzyme is responsible for this conversion.
Decarboxylation of OMP is carried out by OMP decarboxylase (OMPdecase; EC
4.1.1.23), which yields uridine-5- monophosphate (UMP).  The pyrF gene encodes OMP
decarboxylase. UMP is then phosphorylated by a specific UMP kinase to form uridine-
5-diphosphate (UDP).  UMP kinase (UMPk; EC 2.7.4.4) utilizing the gamma phosphate
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of ATP.  UTP is produced by the phosphorylation of UDP by nucleoside
diphosphokinase.  (NDK; EC 2.7.4.6)
The final step in the pyrimidine pathway is the amination of UTP to cytidine-5-
triphosphate (CTP) by the enzyme CTP synthetase.  (CTPase; EC 6.3.42).  For this
enzyme, encoded by pyrG, glutamine serves as the amino donor for the amination.  CTP









































































































































































Salvaging of pyrimidine nucleotides.
The salvage pathway is responsible for the scavenging of pyrimidine nucleotides,
nucleosides and nucleobases that are formed during mRNA and rRNA degradation and
hence recycling them to replenish the lost store and using them as a source of carbon and
energy.  The pyrimidine biosynthetic pathway may be missing in some obligate parasites,
but no organism is devoid of the salvage pathway in one form or another.
D A Beck (1995) has studied the pyrimidine salvage pathway in almost 44
prototrophic bacteria and 11 auxotrophs, which were selected because of specific
mutations that they contained in biosynthetic and salvage pathways O Donovan &
Shanley, 1995).  This study was conducted using High Performance Liquid
Chromatography and offered much insight into the salvage pathways of a wide range of
microorganisms.  The prototype organism used was E. coli and the researcher discovered
8 more variations of the salvage pathways in other organisms.  Through this study, many
groups emerged which differed in the enzymes that were responsible for salvaging
pyrimidines.  Figure 2 and 3 show the enzymes involved in the salvaging of pyrimidine
nucleotides in E. coli and P. aeruginosa respectively.
The following is a general list of all the compounds in the pyrimidine salvage
pathway and how they are utilized in an organism.   Some organisms have two pathways
by which to produce UMP from uracil (U).  The first pathway is the catalysis of uracil by
the enzyme uracil phosphoribosyltransferase (Upp).  One molecule of PRPP is utilized in
this reaction (Anderson et al., 1992).  The second pathway for the formation of UMP can
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be conducted by the enzyme uridine phosphorylase (Udp) when a high amount of ribose-
1-phosphate is present.  Uridine can then be converted to UMP by the enzyme uridine
kinase (Udk).  GTP donates its γ-phosphate for this reaction (Neuhard & Nygaard, 1987).
Cytosine deaminase (CodA) catalyzes the deamination of cytosine to uracil in an
irreversible reaction (West et al., 1982)
Uridine is a substrate for at least 4 different salvage enzymes.  Uridine phosphorylase
(Udp), uridine kinase (Udk), ribonucleoside hydrolase A and B (Rih) and uridine
hydrolase.  In E. coli only the first three of the enzymes have been found (Beck, 1995).
Cytidine in enteric bacteria is phosphorylated to CMP by uridine (cytidine) kinase.  When
cytidine is available to E. coli much of it is converted to uridine by cytidine deaminase
(CodA) by a hydrolytic cleavage (Ashley & Bartlett, 1984).  In Pseudomonas cytidine
has also been shown to be a substrate for ribonucleoside hydrolase (Terada et al., 1967;
Beck, 1995).
The salvaging of pyrimidines is important when one considers that some
organisms do not have a pyrimidine biosynthetic pathway.  If a mutation was to occur in
the biosynthetic pathway (making a pyrimidine auxotroph) the salvage pathway would in
effect take over and continue to make the cell survive.
Breakdown products of mRNA (the 5 mononucleotides UMP and CMP) can be
toxic to the cell and therefore are removed very quickly (O Donovan, 1978).  If they are
allowed to accumulate they will undoubtly cause bacterial cell death.  A mutation that
affected the process of mRNA degradation in a cell would have the result of self
90
destruction.  The cell would die because of the buildup of the toxic 5 monophosphates
(O Donovan & Shanley 1995).
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       RNA                                                                       RNA
CTP UTP
mRNA CDP UDP mRNA
CMP        UMP
   CR         UR
C      U
Fig 2.  Pyrimidine salvage pathway in Escherichia coli.  Enzymes are 1. uracil
phosphoribosyltransferase (Upp), 2. uridine phosphorylase (Udp), 3. ribonucleoside
hydrolase A & B (Rih), 4. cytosine deaminase (CodA), 5. cytidine deaminase (Cdd), 6.
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       RNA                                                                       RNA
CTP UTP
mRNA CDP UDP mRNA
CMP        UMP
   CR      UR
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Fig 3.  Pyrimidine salvage pathway in P. aeruginosa.  Enzymes are 1. uracil
phosphoribosyltransferase (Upp),  2. ribonucleoside hydrolase A & B (Rih), 3. cytosine
deaminase, 4. 5-nucleotidase, 5. CMP glycosylase (Cmg), 6. CMP kinase (Cmk)
Pathway de novo
6




      H2O




   22     5
93
CTP Synthase.
CTP synthase (EC 6.3.4.2) encoded by pyrG catalyzes the following reaction:
GTP
UTP + ATP + L-glutamine             CTP + Lglutamate + ADP + Pi
Mg2+
Ammonia can be substituted for both GTP and glutamine in which case the reaction is
Mg2+
UTP + NH3 + ATP                       CTP + ADP + Pi
The nucleotide CTP plays essential roles in the bacterial cell.  It is required for growth
and metabolism for all organisms and therefore must be available.  CTP is used for the
synthesis of nucleic acids (Traut, 1988) and membrane phospholipids (Kennedy, 1986).
In E. coli the enzyme exists as a dimer (Mr =105,000) of two identical subunits when the
substrates UTP and ATP are not present.  In the presence of UTP, ATP and Mg2+ the
enzyme exists as a tetramer of Mr = 210,000.  (Koshland & Levitzki, 1974;  Koshland,
1978).  The gene encoding CTP synthase has been cloned from Bacillus subtilis (Trach et
al., 1988), Saccharomyces cerevisiae (Ozier-Kalogeropoulos et al., 1991), human beings
(Yamauchi et al., 1990), Azospirillum brasilense (Zimmer & Hundeshagen, 1994),
Cricetulus griseus (Chinese hamster cells, Zhai et al., 1995), Mycobacterium leprae
(Smith & Robison, 1994), Chlamydia trachomatis (Tipples & McClarty, 1995),
Lactococcus lactis (Steen et al., 2001) and Nitosomonas europaea (Mahony & Miller,
1998).  The enzyme contains a conserved glutamine amide transfer domain, which is
characteristic of glutamine amidotranferases.
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The enzyme has been purified to homogeneity from E. coli and it has been characterized
with respect to its kinetic, physical, and enzymological properties.  The enzyme exhibits
complex kinetic properties including negative cooperativity for the effector GTP and the
substrate glutamine.  Positive cooperativity is seen with the substrates ATP and UTP.
This is only if one of the nucleotides varied whilst the other is held at a constant level.
This is under non-saturating conditions.  If one of the nucleotides is saturating then
normal Michaelis-Menten curves are observed for the other substrate. When the
substrates bind a conformational change is observed which facilitates the binding of
subsequent molecules.  The second binding would therefore cause polymerization and
hence facilitate the formation of the tetramer from the dimer (Yang et al., 1994).
CTP synthetase is a key enzyme in the synthesis of pyrimidine nucleotides.
Walsh et al, (1999) discovered that in P. aeruginosa CTP synthetase encoded by
pyrG was the first gene is a tricistronic operon.  The three genes are located at 28.2 to
29.9 min on the P. aeruginosa 75 min map.  The start codon of kdsA is 1 nucleotide
downstream of the stop codon of pyrG and there are 43 nucleotides between the stop
codon of kdsA and the start of eno.  The gene order is therefore pyrG, kdsA and eno (Fig
4).
A sigma 70 (σ70)-like promoter was identified upstream of pyrG but no promoter-
like sequences was detected upstream of kdsA and eno thus suggesting that the three
genes are co-transcribed.  P. aeruginosa produces two types of cell surface
lipolysaccharides (LPS), an A band and a B band which differ in the nature of the O
antigen attached to the lipid A-core (Lam et a.l, 1996).  The lipid A-core is required for
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the stability of the outer membrane and also is shown to contribute to the intrinsic drug
resistant of the organism (Hancock, 1998).  Biosynthesis of the lipid A-core occurs at the
cytoplasmic face of the inner membrane.  The first sugar in the inner core region is 3-
deoxy-D-manno-octulosonic acid (Kdo).  The synthesis of this sugar involves the
condensation of phosphoenolpyruvate and arabinose-5-phosphate by the enzyme Kdo-8-P
synthase encoded by kdsA.  Enolase catalyzes the formation of phosphoenolpyruvate
(PEP) from phosphoglycerate.  PEP is one of the substrates for Kdo-8-P synthase.  CTP
is required to activate Kdo before it is transferred to the lipid-A core (Walsh et al., 1999)
and high amounts of CTP is required during LPS synthesis.  Thus, the presence of these
genes together in an operon in P. aeruginosa is not an accident.  In Chlamydia
trachomatis pyrG is in part of an operon that has another Kdo biosynthetic kdsB gene
immediately upstream (Tipples & McClarty, 1993; Wylie et al., 1996).  In E. coli pyrG
and eno are part of an operon (Weng & Zalkin, 1986) whilst in Nitosomonas europea
pyrG and eno are linked but are separated by 400 bp and most likely transcribed by
separate promoters (Mahony & Miller, 1998).
Analysis of the PAO1 genome did not reveal any other copies of the pyrG and
therefore a mutant that requires cytidine for growth would be a disaster if it were not an


















   















   
















   
   
















































































































































































Regulation of pyrimidine enzymes in P. aerguginosa.
As in Escherichia coli the pyrimidine biosynthetic pathway shares in the
production of UTP and CTP for RNA with the pyrimidine salvage pathway.  While
salvage pathways are essential in providing a balance of RNA synthesis in prototrophs,
they are obligately required to satisfy pyrimidine requirements in auxotrophs.  Salvage
pathways also return mRNA degraded monomers, the 5 monophosphates, to their
triphosphate levels for RNA resynthesis.   A portion of the 5 monophosphates (CMP) is
further degraded to cytosine, which is subsequently deaminated to uracil for the
conversion to UMP.
Pseudomonas aeruginosa lacks the salvage enzyme uridine (cytidine) kinase and
therefore cannot convert uridine to UMP and cytidine to CMP.  Thus, a pyrimidine
auxotroph (Pyr -) in a upp  background cannot grow when fed exogenous uracil.  In the
absence of uridine (cytidine) kinase it is impossible to study the regulation of the
pyrimidine enzymes in P. aeruginosa (Fig 3).
Various authors have shown that in E. coli and S. typhimurium the expression of
aspartate transcarbamoylase (pyrBI), orotate phosphoribosyltransferase (pyrE) and
orotidine-5'-monophosphate decarboxylase (pyrF) is under negative control by a uridine
nucleotide.
A cytidine nucleotide has been shown to exert control on carbamoylphosphate
synthetase (carAB), dihydroorotase (pyrC) and dihydroorotate dehydrogenase (pyrD) (O
Donovan et al., 1989; Smith et al., 1980; Schwartz & Neuhard, 1975).  In the above
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organisms with ~50% G + C, it has been observed that a uridine compound was the
primary repressing metabolite for the expression of pyrB gene.  It is thought that a
cytidine compound may be the primary repressing metabolite in organisms, which have a
higher G + C composition such as P. aeruginosa.
To test this hypothesis it was necessary to isolate a pyrG mutant in Pseudomonas,
in a strain with a functional udk gene.  Such a strain could be fed exogenous cytidine
because it would be a requirement for growth.  Metabolic blocks were created
systematically in P. aeruginosa starting with the isolation of a upp- strain and then
electroporating the E. coli udk gene on the plasmid pDEB1 into this strain.  Expression of
the udk gene was confirmed by 5-fluroanalog plate assays.  By way of an in-frame
deletion and subsequent gene replacement method the CTP synthase (pyrG) was
inactivated on the chromosome.
This hitherto unavailable mutant allowed the independent manipulation of the
intracellular UTP and CTP pools by exogenous feeding of or starving for uridine and
cytidine nucleosides.
Assays for the pyrimidine enzymes encoded by pyrB-F were conducted with the
cells grown in all possible combinations of high and low cytidine and or uridine
nucleoside levels.   
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       RNA                                                                       RNA
CTP UTP
mRNA CDP UDP mRNA
CMP        UMP
   CR      UR
C U
Fig 5.  Red lines show the metabolic blocks that were created in P. aeruginosa so that
uridine and cytidine could be fed to increase the nucleotide pools.  The uridine (cytidine)
kinase gene from E. coli was expressed in P. aeruginosa.  Numbers in boxes represent
the order in which the blocks were created.
Pathway de novo
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Bacterial strains, plasmids, media and growth conditions.
The bacterial strains and plasmids used in this study are listed in Table 1.
Bacteria were grown in Luria-Bertani (LB) enriched medium (Miller, 1992),
Pseudomonas minimal medium (Ornston & Stanier, 1966) supplemented with Hutnerss
Metals 44 (Murray et al, 1981).  For biparental mating experiments transconjugates were
selected on Pseudomonas isolation agar (PIA).  Antibiotics were added at the following
concentrations:  carbenicillin, 600 μg ml-1, ampicillin, 100 μg ml-1 and 50 μg ml-1;
gentamicin, 20 μg ml-1 and 100 μg ml-1.  The carbon source used was glucose at a
concentration of 0.2 %.  All E. coli and P. aeruginosa strains were grown at 37ûC. P.
aeruginosa used for the biparental mating experiment was grown at 42ûC in an attempt to
inactivate its restriction modification system.
Isolation of P. aeruginosa (PAO1) chromosomal DNA.
Chromosomal DNA from P. aeruginosa (PAO1) was isolated using the method
described by Berns & Thomas Jr., (1965).  A starter culture of the above organism was
grown in 5 ml of Pseudomonas minimal medium supplemented with 0.2 % glucose.  A
1% inoculum was used to initiate the growth in a larger volume of 50 ml.  Cells were
grown to an OD600 of 0.5 to 0.7.  The cells were harvested at 1875 xg at 4ûC and placed
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on ice for 20 min.  The cooled cells were washed in 30 ml of a 50 mM Tris pH 8.0 and 20
mM ethylenediamine tetra acetic acid (EDTA) buffer for pelleting at 1875 xg for 20 min.
The pellet was resuspended in 50 ml of the above buffer.  Pronase at 5 mg/ml final
concentration and 0.1 mls 10 % sodium dodecyl sulfate (SDS) were added.  The solution
containing the cells and the buffer were transferred to silconized corex tubes and
incubated at 37ûC for 3 to 8 hrs.  The solution was extracted 4X with an equal volume of
phenol equilibrated with 50 mM Tris-HCl pH 8.0 and 1 mM EDTA.  Phenol
contamination was removed by extracting with 15 ml of diethyl ether.  The DNA was
dialyzed against 3 changes of Tris-EDTA pH 8.0.  The purity and quantity of DNA was
read at 280 nm and 260 nm respectively in as Shimadzu 500 UV spectrophotometer.  A
DNA concentration of .265 μg/μl was recovered using the above preparation.
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Table 2.  List of Strains and plasmids.
Strain or Plasmid Genotype or relevant property
Strains
P. aeruginosa PAO1 Wild type
E. coli
SM10 thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu (knR)
HPS1 e14- (mcrA) recA1 endA1 gyrA96 thi-1 hsdR17 supE44
relA1 Δ(lac-proAB) rif zxx::miniTn5lac4 (lacIQ+ lacZ
ΔM15) rifampicinR chlorophenicolR
Plasmids
pEUK20 E. coli udk gene
pUCP19 E. coli-Ps shuttle vector
pDEB1 780 bp E. coli udk gene subcloned from pEUK20
pCRII AmpR KnR PCR cloning vector
pSPG1 2.1 kb PCR product cloned into PCR II vector
pEXGm GmR: oriT+ SacB+, gene replacement vector with MCS of
pUC18
pEX18ΔpyrG GmR: oriT+ SacB+, gene replacement vector with MCS of
pUC18. pyrG (-195 bp) cloned into the EcoRI and KpnI
restriction sites.
pGmΩ1 AmpR aacC1; gentamicin cassette with omega loops
pGmCJF5 nuh::GmR in pCJF5; Gm cassette cloned into the ScaI site
________________________________________________________________________
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Polymerase chain reaction and cloning of CTP Synthetase (pyrG) from P.
aeruginosa.
Primers for the amplification of pyrG from P. aeruginosa were designed using
Prophet 5.0 gene analysis software.
The upstream primer (5GGTGGCCAACATTCCTGG-3) and the downstream primer
(5-CACGGAACGAGTGGATCG-3) were synthesized by BioSyntheis, Inc.  The 2.1 kb
DNA fragment incorporating the entire pyrG gene from P. aeruginosa was amplified
using Taq polymerase using the method of PCR (Saiki et al., 1988).  The fragment
generated was cloned into the pCRII vector from The Original TA Cloning ® Kit
(Invitrogen) (Fig. 8).  After ligation and transformation into INVαF competent cells,
clones which contained the pyrG gene were selected on LB plus ampicillin 50 μg ml-1,
with 5 bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal) at 0.003% and isopropyl-β-D-
thiogalactopyranoside (IPTG) at 0.03%.  White colonies appearing on the medium were
selected and grown in 5 ml of LB medium with 50 µg ml-1 of ampicillin.  Insertion of the
pyrG gene was confirmed by restriction digestion and by DNA sequencing.  Five positive
clones were isolated and characterized (Fig 9).
Complementation of E. coli JF646.
E. coli JF646, which is auxotrophic for cytidine, was transformed with the plasmids and
the vector controls (pCRII vector).  The transformants were grown on selective medium
which, lacked cytidine.  Complementation was confirmed by the growth of E. coli JF646
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without cytidine and recovering the plasmids from colonies growing on the selective
medium.
Isolation of P. aeruginosa (PAO1) upp‾  mutants.
Wild type strains of P. aeruginosa were grown at 37ûC in 5 ml of Pseudomonas minimal
medium with glucose at a concentration of 0.2%.  The overnight cultures (100 μl) was
spread onto Pseudomonas minimal agar with 0.2% glucose.  Crystals of 5-fluorouracil
were placed in the center of the plate with a sterile spatula.  The plates were incubated at
37ûC for two to three days upon which a zone of killing was observed.  Colonies
appearing within the zone of killing were identified as upp‾ and were picked and grown
in 5 ml of Pseudomonas minimal medium to confirm the genotype.  The overnight
culture was spread onto a new Pseudomonas minimal medium plate.  Crystals of 5-
fluorouracil were placed in the center of the plate.  The plates were incubated for two
days.  The upp‾ mutant was confirmed by the growth of the cells up to the 5-fluorouracil
crystals in the center of the plate.
Preparation of Electro competent upp‾ P. aeruginosa (PAO1).
A single colony of P. aeruginosa upp‾ cells were inoculated into 5 ml of Pseudomonas
minimal medium.  The cells were grown at 37ûC at 250 rpm.  100 μl of the culture were
used as the inoculum for 100 ml of Pseudomonas minimal medium.  The cells were
grown at 37ûC to an OD600 of 0.5 to 0.7 was reached.  The flask was chilled on ice for 20
min and transferred to two chilled 50 ml centrifuge tubes.  The sample was centrifuged at
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5000 xg for 20 min at 4ûC.  The pellet was gently resuspened by swirling in 10 ml of ice
cold H2O.  The above step was repeated 5 times.  The cells were resuspended in 5 ml of
ice-cold H2O and centrifuged at 5000 xg for 10 min.  The pellet was resuspended in 2 ml
of 10% glycerol (v/v) and transferred to pre-chilled microcentrifuge tubes in 50 μl
aliquots.  The cells were frozen on dry ice and stored at -80ûC until use.
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Confirmation of the expression of uridine (cytidine) kinase (udk) in P. aeruginosa by
flouroanalog plate assays.
P. aeruginosa upp‾  mutants transformed with the plasmid pDEB1 were grown
overnight in 5 ml of Pseudomonas minimal medium with 0.2% glucose and 600 μg ml-1
of  carbencillin.  One hundred μl of the overnight culture was spread plated onto
Pseudomonas minimal agar which was then divided into two halves.  On one side of the
plate, crystals of fluorocytidine were placed in the center whilst on the other side crystals
of fluorouridine was placed.  A zone of killing would indicate the expression of the E.
coli uridine (cytidine) kinase gene in P. aeruginosa.
Cloning of the P. aeruginosa CTP synthase gene (pyrG) into pUCP19.
A 2.1 kb DNA fragment containing the entire pyrG gene was excised from the
plasmid pSPG1 using the restriction enzymes KpnI and EcoRI.  The DNA fragment was
agarose gel purified and ligated into the pUCP19 plasmid, which had also been digested
with the same enzymes.  After ligation and transformation into DH5α competent cells,
clones, which contained the pyrG gene were selected on LB plus ampicillin 100 μg ml-1,
with X-gal at 0.003% and IPTG at 0.03%.  White colonies appearing on the medium were
selected and grown in 5 ml of LB medium with 100 µg ml-1 of ampicillin.  Upon
confirmation of the cloned gene of the appropriate size the plasmid was digested with the
restriction enzyme BssHII.  This enzyme was chosen because it would remove a portion
(~195 bp) from the internal region of pyrG, however it would not cut the plasmid DNA.
The linearized plasmid with the 195 bp deletion was agarose gel purified using Gelase
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and circularized using T4 DNA ligase.  This method created an in-frame deletion of the
pyrG gene (Fig 10).
Cloning of ΔpyrG into the suicide vector pEX18Gm.
pEX18Gm (Genbank Accession number AF047518) is a gene replacement vector
which was developed by Hoang et al, (1998) (Fig 11).  This vector is useful for gene
replacement studies in P. aeruginosa.  The vector incorporates (i) A counter-selectable
sacB marker, (ii) a lacZα-allele for blue white screening, (iii) the multiple cloning site
from pUC18 and, (iv) gentamicin resistance gene.  The plasmid can be used to replace
wild type gene sequences with cloned genes because it allows for one to track the gene
replacement process.  Thus this plasmid was used for the replacement of the wild type
pyrG sequence with the ΔpyrG.  The ΔpyrG gene was excised from pUCP19 using the
restriction enzymes Kpn I and Eco RI.  The 1.756 bp pyrG gene was agarose gel purified
and cloned into plasmid pEX18Gm, which had been digested with the same enzymes.
After ligation and transformation into DH5α competent cells, clones, which contained the
ΔpyrG gene were selected on LB plus gentamicin 20 μg ml-1, with X-gal at 0.003% and
IPTG at 0.03%.  White colonies appearing on the medium were selected and grown in 5
ml of LB medium with 20 µg ml-1 of gentamicin.  Plasmid DNA was isolated using the
alkaline lysis method.  Insertion of the ΔpyrG gene was confirmed by restriction digest
and agarose gel electrophoresis.
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Preparation of competent cells.
All E. coli SM10 and E. coli HPS1 competent cells for transformation
experiments were prepared using the calcium chloride method of Dagert & Ehrich (1979)
with slight modifications. The cultures were grown in 50 ml of E. coli minimal medium
with the appropriate antibiotics to an OD600 of 0.2 to 0.4 and chilled on ice at 0 to 4◦C for
10 min.  The cells were harvested by centrifugation at 1875 xg at 4◦C for 15 min, the
pellet was resuspended in 20 ml of ice cold 0.1 M CaCl2 and incubated on ice for 20 to 25
min.  The cells were centrifuged at 833 xg at 4◦C for 15 min, the pellet was resuspended
in 0.7 ml of ice cold CaCl2 and incubated overnight on ice.  The following day glycerol
was added to a final concentration of 15% and the cells were separated into 200 µl
aliquots.  Cells were then frozen at 80◦C and could used for up to three months.
Transformation of E. coli HPS1 and E. coli SM10 with pEX18Gm ΔpyrG.
Transformation of E. coli HPS1 with the plasmid pEX18 ΔpyrG (Fig 12) ), was
conducted according the method described by Huff et al, (1990).  Approximately 40 ng
of plasmid DNA were mixed with 200 µl of the CaCl2 treated cells and the mixture was
incubated on ice for 15 min.  The cells were then heat shocked at 42ûC for 2 min, and
then placed back into the ice bucket for a further 15 min.  LB broth at a volume of 1 ml
was added to the cells, which were then incubated at 37ûC for 1 h.  After 1 h the cells
were plated on LB medium, plasmid insertion was selected for by gentamicin resistance
at a concentration of 20 µg ml-1.
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Transformation of E. coli SM10 with the plasmid pEX18ΔpyrG (Fig 12), was conducted
according the method described by Huff et al, (1990).  E. coli SM10 cells were used for
the biparental mating experiment because it allows for the mobilization of plasmid
sequences into the chromosome of wild-type cells.   Approximately 40 ng of plasmid
DNA were mixed with 200 µl of the CaCl2 treated cells and the mixture was incubated on
ice for 15 min.  The cells were then heat shocked at 42ûC for 2 min, and then placed back
into the ice bucket for a further 15 min.  LB broth at a volume of 1 ml was added to the
cells, which were then incubated at 37ûC for 1 h.  After 1 h the cells were plated on LB
medium, plasmid insertion was selected for by gentamicin resistance at a concentration of
20 µg ml-1.
Isolation of pyrG‾  (cytidine requiring mutants) by biparental mating.
The gene replacement plasmid, pEX18 ΔpyrG, was mobilized into P. aeruginosa
PAO1 upp-, udk+, by biparental mating as described by De Lorenzo & Timms (1994).
Five ml cultures of E.coli SM10 harboring the pEX18 ΔpyrG plasmid (donor strain) were
grown at 37◦C overnight in LB medium.  Five ml cultures of P. aeruginosa (PAO1, upp-,
udk+) were grown in Pseudomonas minimal medium with µg ml-1 carbenicillin 600 at
42◦C overnight in an attempt to inactivate its restriction modification system (recipient
strain).  40 μl of the recipient strain (P. aeruginosa, PAO1) were placed into a sterile
microfuge tube and pelleted at 12,000 xg in a bench top centrifuge.  The cells were
washed 3 times with sterile phosphate buffered saline (pH 7.3).  40 μl of the donor strain
was added to the same tube and the above procedure was again performed.  The donor
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and recipient cells were transferred to a 15 ml tube, which contained 5 ml of 10 mM
MgSO4.  The solution containing the donor and recipient strain were transferred to a 5 ml
sterile syringe, which had a Nalgene filter unit containing a 0.45 μm
 Filter.  The solution was pushed through the filter unit.  The apparatus was disassembled
and the filter was removed with sterile forceps and placed on an LB agar plate bacteria
side up.  The plate was incubated at 37◦C for 16 to 18 h.  Sterile forceps were used to
remove the filter off the LB plate and it was placed into a tube containing 10 ml of 10
mM MgSO4.  The bacteria were resuspened in the solution and serial dilutions of 10‾1,
10‾2, 10‾3, 10‾4 were made.  The serial dilution of 10‾3 was plated on PIA plates
supplemented with 50 µg ml-1 of cytidine and incubated at 37◦C overnight.  PIA plates
select against E. coli strains.  Colonies appearing on the plates were replica-plated on 3
plates.  Plate 1 was Pseudomonas minimal medium supplemented with 50 µg ml-1
cytidine, 100 µg ml-1 gentamicin and glucose at a concentration of 0.2% as the carbon
source.  Plate 2 was Pseudomonas minimal medium supplemented with 50 µg ml-1
cytidine, carbenicillin at 600 µg ml-1 and glucose at a concentration of 0.2 %.  Plate 3 was
Pseudomonas minimal medium supplemented with 50 µg ml-1 cytidine, 10 % sucrose,
carbenicillin 600 µg ml-1 and glucose at 0.2 %.  Colonies that were sucrose sensitive,
carbenicillin resistant and gentamicin resistant were picked and inoculated into 5 ml LB
broth supplemented with cytidine at a concentration of 50 µg ml-.  The tube was
incubated overnight at 37◦C to increase the number of double crossovers.  Serial dilutions
10‾1, 10‾2, 10‾3, 10‾4 were made and 100 μl of the 10‾3 dilution was plated onto
Pseudomonas minimal agar plates supplemented with cytidine at 50 µg ml-1 and
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carbenicillin at 600 µg ml-1.  Transconjugates were replica-plated onto 3 plates.  Plate 1
was Pseudomonas minimal medium supplemented with 50 µg ml-1 cytidine, 100 µg ml-1
gentamicin and glucose at a concentration of 0.2% as the carbon source.  Plate 2 was
Pseudomonas minimal medium supplemented with 50 µg ml-1 cytidine, 600 µg ml-1
carbenicillin and glucose at a concentration of 0.2 %.  Plate 3 was Pseudomonas minimal
medium supplemented with 50 µg ml-1 cytidine, 10 % sucrose, 600 µg ml-1 carbenicillin
and glucose at 0.2 %.  Colonies of ,phenotype carbenicillin resistant, sucrose resistant,
gentamicin sensitive and cytidine-requiring were isolated.  These colonies were
designated PAO1 upp-, udk+, pyrG-.  Strains were confirmed for the requirement of
cytidine by plating on Pseudomonas minimal agar with and without cytidine.
Small scale chromosomal isolation of wild-type and mutant pyrG- strains.
 Small scale genomic DNA preparation from wild type P. aeruginosa (PAO1) and
5 cytidine-requiring mutants was conducted.  Five ml of each of the samples were grown
independently to saturation overnight.  1.5 ml of the overnight culture was transferred to
a microfuge tube and the cells were pelleted for 2 min at 10,000 xg.  The cells were
resuspended in 575 μl of Tris-EDTA solution and resuspeneded by repeated pipetting.  30
μl of 10 % (w/v) SDS and 3 μl of 20 mg proteinase K ml-1 was added.  The samples were
mixed and incubated at 37◦C for 1 h.  100 μl of 5 M NaCl was added and mixed
thoroughly.  80 μl of CTAB/NaCl was added and the mixture was incubated at 65◦C for
10 min.  An equal volume of 24:1 chloroform/isoamyl alcohol was added, the mixture
was mixed thoroughly and centrifuged for 5 min at 12,000 xg.  The supernatant was
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removed to a fresh microfuge tube and the sample was extracted with 25:24:1
phenol/chloroform/isoamyl alcohol and placed into a fresh tube.  DNA was precipitated
by the addition of 600 μl of isopropanol centrifuged and washed once with 70 % ethanol
and dried briefly in a vacuum dessicator.  The quantity and the protein contamination of
the DNA samples were measured by UV spectrophotometer at Abs260 and Abs280
respectively.
Verification of pyrG deletion in mutant strain by PCR.
The deletion of the pyrG gene and its subsequent integration into P. aeruginosa
(PAO1, upp-, udk+) chromosome was verified by PCR (Saiki, 1988) on chromosomal
DNA extracted from the strain.  The DNA from five mutant strains and wild-type DNA
was extracted using the above method.  The PCR primers initially used to isolate the
pyrG gene were used to verify the deletion using Taq DNA polymerase.  The following
conditions for the PCR reaction were used:  Step 1:  denaturation at 95○C for 5 min, Step
2: denaturation at 95○C for 2 min, Step 3:  Annealing at 56○C for 1 min, Step 4:
polymerisation at 72○C for 3 min, Step 5: repeat step 2-4 29 times, Step 6:  72○C for 5
min and Step 7:  4○C for 99 h.  Products formed by the PCR reaction were observed using
agarose gel electrophoresis.
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Inactivation of the uridine hydrolase gene (nuh) by gentamicin cassette mutagenesis
in specially constructed cytidine requiring strains of P. aeruginosa.
The P. aeruginosa uridine hydrolase gene was cloned into the pZero vector to
produce the plasmid pCJF5 by Christopher Fields in our lab.  A 1.6 kb SmaI fragment
containing the gentamicin-resistant (Gm) cassette was isolated from plasmid pGMΩ1
(Fig 13) (Schweizer, 1993).  A ScaI digest of pCJF5 allowed for the direct insertion of
the Gm cassette into the internal region of uridine hydrolase gene (Fig 14).
P. aeruginosa upp-, udk+, pyrG- was made electrocompetent and the plasmid was
electroporated into the cells as described above.  The cells were plated on Pseudomonas
minimal agar supplemented with 50 µg ml-1 cytidine and 20 µg ml-1uridine.  The
antibiotics 600 µg ml-1 carbenicillin, 200 µg ml-1  gentamicin were added at the mentioned
concentrations.
Confirmation of a uridine hydrolase (nuh) mutant in P. aeruginosa.
Pseudomonas minimal agar plates supplemented with uridine and cytidine at a
concentration of 50 µg ml-1 were streaked with P. aeruginosa upp-, udk+, pyrG- nuh+.
Another plate with the same supplements was streaked with the isogenic P. aeruginosa
upp-, udk+, pyrG- nuh-.  If the P. aeruginosa upp-, udk+, pyrG - nuh  grew on the plate
then this would prove that they are not uridine hydrolase mutants because of the uridine
hydrolases ability to make ribose, which could satisfy the carbon source requirement.
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Growth conditions of pyrG-, upp-, udk+ nuh- strains for pyr assays.
P. aeruginosa upp-, udk+, pyrG- nuh- and its isogenic P. aeruginosa upp-, udk+, pyrG-,
nuh- strains were grown in Pseudomonas minimal medium under var conditions of high
and low uridine and cytidine.  At least 50 µg ml-1 of cytidine was required for the cells to
grow successfully.   All mutant strains were grown with glucose as the carbon source,
600 µg ml-1 carbenicillin and 200 µg ml-1 gentamicin.   Table 2 describes the various
conditions concentrations of uridine and cytidine used.
Table 2
Strain Condition for growth
________________________________________________________________________
P. aeruginosa      UR20 and CR50, UR200 and CR200,
 UR20 and CR200, and UR200 and CR50
P. aeruginosa upp-, udk+, pyrG- UR20 and CR50, UR200 and CR200,
 UR20 and CR200, and UR200 and CR50
P. aeruginosa upp-, udk+, pyrG-, nuh- UR20 and CR50, UR200 and CR200,
 UR20 and CR200, and UR200 and CR50
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Preparation of cell extract for pyr enzyme assays.
All strains were grown in 100 ml of Pseudomonas minimal medium with the
necessary additions.  Bacteria were grown to 100 Klett units and harvested by
centrifugation at 6,000 xg for 20 min.  The cells were resuspended in 1 ml of 40 mM
phosphate buffer pH 8.0.  Cells were disrupted by sonication and transferred to a
microfuge tube.  The clarified extract was centrifuged at 10, 000 xg for 4 min at which
time a 200 μl sample was removed and placed into a sterile tube for dihydroorotate
dehydrogenase (pyrD) encoded enzyme assays.  The remainder was centrifuged at 12,
000 xg for a further 20 min.  The supernantant was removed for enzymes encoded pyrB-
pyrF.
Enzyme assays.
All assays were carried out at 37ûC.  Changes in absorbance were monitored
spectrophotometrically using a Shimadzu UV-mini spectrophotometer 1240.  Specific
activites of the enzymes assayed were determined under conditions in which product
formation (or substrate utilization) was proportional to extract and time and expressed as
μmol min-1 mg-1 protein.  All values represent the mean of three independent
determinations.
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Aspartate transcarbamoylase (ATCase) assay.
 ATCase enzyme assays were performed using the method described by Gerhart
& Pardee (1962). The specific activity (μmol min-1 mg-1) was determined by monitoring
the enzymatic production of carbamoylaspartate (CAA) in 10 min at 37°C using the
colorimetric method of Prescott & Jones (1969).  A 1 ml reaction volume contained the
following components: 40 µl of Tri-buffer (Ellis & Morrison, 1982), pH 9.5, (51 mM
diethanolamine, 51 mM N-ethylmorpholine and 100 mM MES), 50 µl of 100 mM
potassium aspartate (pH 9.5), 100 µl of 50 mM carbamoylphosphate (dilithium salt), 10
µl of clarified extract, 800 µl ddH2O.  In addition to the reaction tubes, a control was also
prepared by substituting ddH2O for larified extract.  The ATCase assay tubes were
prepared in advance, without the addition of carbamoylphosphate, and preincubated at
37°C for 2 min.  The reaction was initiated by the addition of carbamoylphosphate and
the tubes were incubated at 37° for 10 min. After 10 min, the reaction was terminated by
the addition of 1 ml of color mix (2 parts of 5 mg ml-1 of antipyrine in 50% sulfuric acid
(v/v) with 1 part of 8 mg ml-1 of 2, 3-butanedione monoxime in 5% acetic acid (v/v)).
The reaction tubes were mixed by vigorous vortexing, and incubated at 65°C for 2 h in
the light to allow development of the color.  The tubes were capped with marbles to
minimize evaporation.  After 2 h, the absorbance units at 466 nm (A466) was measured,
using the control tube to blank the spectrophotometer.  The μmoles of CAA produced
were determined using a CAAstandard curve, prepared with known concentration of
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CAA ranging from 25 to 300 μM in the standard assay reaction mix and under the same
color development conditions .
Dihydroorotase (DHOase) assay.
The DHOase assay tubes contained the following components in a 1 ml reaction
volume: 100 µl of 1 M Tris (pH 8.6), 100 µl of 10 mM EDTA, 100 µl of 20 mM
dihydroorotate (in 0.1 M phosphate buffer, pH 7.5), 10 µl clarified extract and 690 µl of
ddH2O (Beckwith et al., 1962).  The DHOase assay tubes were prepared in advance,
without the dihydroorotate, and pre-incubated at 37°C for 2 min. The reaction was
initiated by the addition of dihydroorotate and the tubes were incubated at 37°C for 10
min. After 10 min, the reaction was terminated by the addition of 1 ml of color mix, the
tubes were vortexed and incubated at 65°C for 2 h in the light.  The A466 units were
measured using a control tube, containing all reaction components except dihydroorotate,
to blank the spectrophotometer.
Dihydroorotate dehydrogenase assay.
Dihydroorotate dehydrogenase activity was measured spectrophotometrically by
monitoring the conversion of dihydroorotate to orotate at 290 nm.  The dihydroorotate
dehydrogenase reaction mix was prepared in a quartz cuvette containing the following
components in a 1 ml reaction volume: 0.1 M Tris (pH 8.6), 6 mM MgCl2, 1 mM
dihydroorotate (in 0.1 M phosphate buffer, pH 7.5), 50 µl clarified extract and ddH2O to
a 1 ml total volume.  The reaction cuvette was prepared in advance, without the
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dihydroorotate, and incubated at 37°C for 2 min. The reaction was initiated with the
addition of dihydroorotate, and the A290 units were noted immediately, this was the blank
reading.  The cuvette was then incubated at 37°C for 10 min, after which the A290 units
were measured.  The blank reading was subtracted from the 10 min reading.  An increase
in absorbancy of 1.93 is equivalent to a change in substrate concentration of 1 mM
(relative to the blank reading).
Orotate phosphoribosyltransferase (OPRTase) assay.
OPRTase activity was measured spectrophotometrically by the method of Smith
et al., (1980).  The conversion of orotate to OMP was monitored at 295 nm.  The
OPRTase reaction mix was prepared in a quartz cuvette containing the following
components in a 1 ml reaction volume: 0.1 M Tris (pH 8.6), 6 mM MgCl2, 0.25 mM
orotate, 0.6 mM 5-phosphoribosyl-1-pyrophosphate (PRPP), 50 µl clarified extract and
ddH2O to a 1 ml total volume.  The reaction cuvette was prepared in advance, without the
orotate, and incubated at 37°C for 2 min. The reaction was initiated with the addition of
orotate, and the A295 units were recorded immediately, this was the blank reading.  The
cuvette was then incubated at 37°C for 10 min, after which the A295 units were measured.
The 10 min reading was subtracted from the blank reading.  A decrease in absorbancy of
3.67 is equivalent to an increase in orotidine 5-monophosphate (OMP) concentration of
1 mM (relative to the blank reading).
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OMP decarboxylase assay.
OMP decarboxylase activity was measured spectrophotometrically by monitoring
the conversion of OMP to uridine 5-monophosphate (UMP) at 285 nm.  The OMP
decarboxylase reaction mix was prepared in a quartz cuvette containing the following
components in a 1 ml reaction volume: 0.1 M Tris (pH 8.6), 6 mM MgCl2, 0.2 mM OMP,
50 µl clarified extract and ddH2O to a 1 ml total volume.  The reaction cuvette was
prepared in advance, without the OMP, and incubated at 37°C for 2 min.  The reaction
initiated with the addition of OMP, and the A285 units were noted immediately, this was
the blank reading.  The cuvette was then incubated at 37°C for 10 min, after which the
A285 units were measured.  The 10 min reading was subtracted from the blank reading.  A
decrease in absorbancy of 1.38 is equivalent to a decrease in OMP concentration of 1 mM




Fig 6.  Plasmid pUCP19.  The plasmid contains the ampicillin resistant gene which






Fig 7.  Construction of pDEB (Beck, 1995).  The plasmid contains the E. coli












Fig 8 Schematic diagram of pCR II vector (Invitrogen).  The multiple cloning site is
located within the lacZα gene which allows for blue, white selection.  The plasmid
contains a kanamycin and ampicillin resistant gene.
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Fig 10.  Construction of the pyrG deletion in pUCP19.  The 2.0 kb pyrG gene was cloned
into pUCP19 and the geletion was conducted in the plasmid by digesting with the BssHII
enzyme.
2.0 kb pyrG gene cloned into pUCP19,
restriction digest with BssHII enzyme
to delete 195 bp





Fig 11.  Gene replacement plasmid pEX18Gm.  Plasmid size is 5.831 kb and has the
convienient multiple cloning site of pUC18.  This vector has the gentimicin resistant
marker and the Bacillus subtilis SacB gene, which confers sucrose sensitivity and thus










Fig 12.  Gene replacement plasmid containing the deleted 1.756 kb pyrG gene subcloned
from pUCPΔpyrG.  This plasmid was used to replace the wild type pyrG gene in P.
aeruginosa upp-, udk+.
   pEX18GmΔG
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Fig 13. Small broad host range plasmid pGmΩ1 plasmid (Schweizer, 1993).  The
plasmid contains the 1.6 kb gentamicin resistant gene cassette.  The gentamicin resistant
cassette can be used for site specific insertion and deletion mutagenesis.








Fig 14.  Schematic diagram of pCJF5.  The resulting 7.3 kb plasmid contains the 1.6 kb
gentamicin cassette fragment, digested from pGMΩ1 (Schweizer, 1993).  The Gm
cassette was cloned into the Sca1 restriction site of plasmid pCJF5.  Expression of uridine






Chromosomal DNA from P. aeruginosa was prepared and used to conduct PCR
using the method described by Saiki et al (1988).  A product of the size 2.0 kb was
produced and was subsequently cloned into the pCRII vector (Invitrogen) to produce
the construct pSPG1 (Fig 8).  The isolation of the pyrG gene was confirmed by
complementing the E. coli pyrimidine auxotroph JF646.
_+.2*#$.7'.,'P. aeruginosa uppT +#-*$7H
The pyrimidine analog 5- fluorouracil was used to isolate a P. aeruginosa upp-
mutant.  A pyrimidine analog is a pyrimidine base which has an additional functional
group attached to one of the members of the pyrimidine ring.  The analog 5fluorouracil
has a fluoro group attached to the number 5 carbon on the pyrimidine ring.  In a bacterial
cell the analog is recognized as a uracil compound and is quickly taken up by the enzyme
uracil permease (uraA).  Next uracil phosphoribosyltransferase encoded by the upp gene
converts it to FUMP.  The ultimate toxic compund molecule is 5FdUMP, which inhibits
thymidylate synthase.
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Fig 15.  A photograph of the pyrG gene isolated from PAO1 chromosomal DNA.  The











In any given population of bacteria some cells are naturally resistant to 5- fluorouracil,
upp-.  These upp mutants have no uridine phosphoribosyltransferase and thus are unable
to catalyze the reaction of fluorouracil to fluorouridine 5 monophosphate (FUMP).  In
this study I have isolated a P. aeruginosa upp- strain, which is resistant to 5 fluorouracil
(Fig 16).  Figure 16 shows the plate assay performed in order to isolate such a mutant.
Crystals of 5-fluorouracil were placed in the middle of the plate.  P. aeruginosa upp-
mutants were able to grow right up to the crystals.   This was the first step in reaching
that pot of gold at the end of the rainbow, which in my case the pot of gold is excluded
and all that I am left with is the wish of finding pyrG mutants in Pseudomonas.
@\1-&++$.7'.,'#4&'E. coli 0-$3$7&'8"6#$3$7&>'K$7*+&'8udk>'S&7&'$7'P. aeruginosaH
        Organisms with a functional uridine (cytidine) kinase gene are sensitive to the
pyrimidine analog 5-fluorouridine because the enzyme can catalyze the reaction of FUR
to FUMP, which is toxic to the cell.  Such organisms are also sensitive to
5fluorocytidine because uridine (cytidine) kinase can also catalyze the reaction of
cytidine to CMP and ultimately CTP.  5-fluorocytidine can be converted to the toxic
nucleotide levels.
       Beck (1995) showed that P. aeruginosa does not possess a functional uridine
(cytidine) kinase and does not have a cytidine deaminase gene.  She cloned the E. coli
udk gene into pUCP19.  This construct was named pDEB1 (Fig 7).  By finding that P.
aeruginosa became sensitive to FUR and FCR only after she introduced the E. coli
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uridine (cytidine) kinase gene.  Beck showed that the introduced udk was expressed in P.
aeruginosa.
I used this plasmid to electroporate it into a P. aeruginosa upp- strain.
I plated the transformed cells onto Pseudomonas minimal medium and then placed
crystals of 5-fluorouridine and 5-fluorocytidine in the middle of the plate.  The results of
this experiment showed a zone of killing around the FUR and FCR crystals.  The zone of
killing indicates that the udk gene can be expressed in P. aeruginosa upp-  (Fig 17).
       Until a functional uridine (cytidine) kinase was incorporated into P. aeruginosa it
was not possible to convert UR (FUR) or CR (FCR) to their nucleotide derivatives.  Once
udk was expressed, it became possible to feed exogenous nucleosides to pyrimidine
auxotrophs as well as sensitizing P. aeruginosa to FUR and FCR.  Thus, the isolation of a
pyrG mutant became feasible.  This in turn allowed the independent manipulation of the
UTP and CTP pools.
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Fig 16.  P. aeruginosa PAO1 upp- strain isolation.  Crystals of 5 fluorouracil were
placed in the center of the plate.  No zone of killing was observed.
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Fig 17.  Expression of the E. coli uridine (cytidine) kinase gene is P. aeruginosa PAO1
upp- strain.  On the left half of the plate crystals of fluorouridine were placed in the and
on the right half of the plate crystals of fluorocytidine were placed.  Zones of killing
indicate the expression of the udk gene.
   FUR FCR
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_+.2*#$.7'.,'"6#$3$7&'-&`0$-$7S'/0#*7#+'$7'P. aeruginosaH
       CTP synthase mutants were isolated using the in-frame deletion technique described
by Schweizer and Houng (1993).  The pyrG gene was sub-cloned from pSPG1 into the
pUCP19 vector.  An in-frame deletion was created in this vector by restriction digest
using the enzyme BssHII.  This restriction enzyme created a 195 bp deletion in the
internal region of the pyrG gene.  The vector was circularized and the truncated fragment
was cloned into the gene replacement vector pEX18Gm (Fig 10, 11 & 12).  The pEX18
pyrG plasmid was incorporated into the P. aeruginosa upp- udk+ strain by the method of
biparental mating described by De Larenzo & Timms (1993).
Like its E. coli counterpart the pyrG gene of P. aeruginosa encodes CTP synthase.  This
was confirmed by genome analysis and only one copy of the gene was found.  The
disruption (deletion) in pyrG resulted in the cells requirement for 50 μg ml-1cytidine,
pyrG mutants are cytidine auxotrophs.
In E. coli and S. typhimurium cytidine is rapidly deaminated to uridine by cytidine
deaminase.  Accordingly, in E. coli pyrG mutants must be isolated in a cdd- background.
P. aeruginosa does not have this enzyme but instead has a very active nucleoside
hydrolase, which must be mutated along with pyrG to study regulation.  This is discussed
below.  Chromosomal DNA from P. aeruginosa wild type cells and the mutants isolated
was prepared.  PCR was conducted to confirm the presence of the deleted pyrG gene (Fig
18).
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Fig 18.  Verification of pyrG inframe deletion in P. aeruginosa PAO1 upp- udk+.  Lane1
1 kb ladder, Lane 2 Negative control, Lane 3 Wild type, Lane 4 Negative control, Lane 5-








)*++&##&'/0#*S&7&+$+'.,'0-$3$7&'463-.2*+&'$7'P. aeruginosa uppT udka pyrGTH
       The uridine hydrolase gene was shown to be very active in P. aeruginosa by
Christopher Fields (unpublished data, 2001).  This caused a problem because uridine was
added to the medium to feed the cells and to elevate the UTP pools in P. aeruginosa.
Initial pyr enzyme assays did not show much effect on the de novo enzymes.  This led to
the conclusion that the uridine added was rapidly broken down to uracil by uridine
hydrolase.  Indeed, Fields showed that the hydrolase was induced by growth on uridine.
The uracil was excreted into the surrounding medium.  Therefore it was imperative to
construct a uridine hydrolase mutant in the P. aeruginosa upp- udk+ pyrG-.  A 1.6 kb
gentamicin cassette was inserted into the middle of the uridine hydrolase gene.  The
resultant construct was electroporated into the above strain.  The mutation was confirmed
by plating the cells onto Pseudomonas minimal medium, which had uridine or cytidine
only as the carbon source.  A uridine hydrolase plus mutant would be able to break these
compounds down and use the ribose liberated as a carbon source.  A uridine hydrolase
minus mutant would not be able to do this.  Inability of the cells to use uridine or cytidine




Enzyme assays for ATCase (pyrB), DHOase (pyrC), DHOdecase(pyrD), OPRTase
(pyrE) and OMPdecase (pyrF) were carried out on the specially constructed cytidine
requiring mutants.  The cells were grown in 100 ml of Pseudomonas minimal medium
with the appropriate antibiotics.  This experiment allowed us to ascertain the effects on
the pyr enzymes when the cells were grown in different levels of uridine and or cytidine.
In a pyrG- upp- udk+ the specific activity for the enzyme ATCase was 342 μmol min-1 mg-
1 protein.  In comparison the specific activity of the pyrG- upp- udk+ nuh- was 71 μmol
min-1 mg-1 protein.   This showed that when the level of uridine was high (200 μg ml-1)
and cytidine low (50 μg ml-1) there is a 5-fold repression of the enzyme ATCase,
suggesting that a uridine compound (UMP, UDP or UTP) is the primary repressing
metabolite for ATCase (Table 3, Fig 19).
       A more dramatic change was observed in the enzyme dihydroorotase.  When uridine
and cytidine levels were at 20 μg ml-1 and 50 μg ml-1 there was a 5-fold repression of the
enzyme.  When both uridine and cytidine were at 200 μg ml-1 there was a 4.6-fold
repression in the enzyme.  The most change observed in the enzyme was when uridine
was 200 μg ml-1 and cytidine was 50 μg ml-1.  Then there was a 9-fold repression in the
enzyme.  This again suggests that a uridine compound or high UTP has a repressive
effect on the DHOase enzyme (Table 4, Fig 20).
       For the enzyme encoded by pyrD, a 2-fold repression was observed when the cells
were grown in high uridine and low cytidine.  This result is not as significant as those
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observed for the earlier enzymes in the pathway (Table 5, Fig 21).  When the cells were
grown in high uridine and low cytidine the enzyme OMP decarboxylase was derepressed
1.4-fold in the pyrG- upp- udk+ nuh- when compared to pyrG- upp- udk+ (Table 6, Fig 22).
Finally the enzyme encoded by pyrF was repressed 3-fold when grown in high uridine
and low cytidine (Table 7, Fig 23).
       This is the first study to be done with the proper necessary mutants in the
biosynthetic pathway of P. aeruginosa.  In the past it has been impossible to vary the
internal pools of UTP and CTP for the lack of a pyrG mutation.  Currently work is
underway in our laboratory to quantify these pools by way of High Performance Liqiud
Chromatography.  This will provide ultimate data to discover if a uridine or a cytidine
nucleotide is the primary repressing metabolite.
       None of this would be possible without the presence of a functional uridine (cytidine)
kinase in P. aeruginosa.  This presence allowed the isolation of a pyrG mutant, which in
turn required a nucleoside mutant for full expression.
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Table 3.  Specific activities (ATCase) in upp- pyrG- udk+ strain, and its isogenic upp-




upp- pyrG- udk+     75         258                  342         123
upp- pyrG- udk+ nuh-    106                        98          71         78
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Table 4.  Specific activities (DHOase) for upp- pyrG- udk+ strain, and its isogenic upp-




upp- pyrG- udk+     49         57                     43         26
upp- pyrG- udk+ nuh-    9.3                     12.4          4.9        10
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Table 5.  Specific activities (DHOdecase) for upp- pyrG- udk+ strain, and its isogenic upp-




upp- pyrG- udk+     42          61                   49           26
upp- pyrG- udk+ nuh-     36                         32         27          31
143
Table 6.  Specific activities (OPRTase) for upp- pyrG- udk+ strain, and its isogenic upp-




upp- pyrG- udk+      81         44                    36           37
upp- pyrG- udk+ nuh-     115                      25         52          69
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Table 7.  Specific activities (OMPdecase) for upp- pyrG- udk+ strain, and its isogenic upp-




upp- pyrG- udk+     23         22                    72        11
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